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ABSTRACT 
This study aimed to  (1) characterize substance use treatment preferences, barriers, and 
attitudes in an under-represented sample of pregnant and postpartum women; (2) examine 
associations between barriers and help-seeking preferences, treatment attitudes, treatment 
engagement, substance use, and well-being; and (3) examine moderating effects of culture.  
Participants were 27 women, most of whom were treatment-experienced, of ethnic minority 
status, and from lower-income households. Results indicated flexibility in treatment preferences, 
and positive attitudes about treatment despite an extensive number of barriers. Participants 
indicated greater interference from stigma, relative to instrumental barriers. Qualitative responses 
revealed unique barriers experienced by this sample, and offspring well-being was most 
frequently mentioned as a factor motivating treatment engagement.  Aim 2 associations were not 
demonstrated. However, limiting analyses to an ethnic minority subsample revealed unique 
associations of acculturation and enculturation with each other and family-related treatment 
barriers. Conclusions include implications for intervention and future research with this 
population.  
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Introduction 
Maternal substance use poses significant risks to the physical health and well-being of 
both mother and child, and is associated with significant distress within the family.  Prenatal 
substance use has been associated with poorer infant health indicators at birth including 
premature birth, low infant weight, fetal alcohol spectrum syndrome, substance withdrawal 
symptoms, and later problems such as delayed mental and motor development (Behnke & Eyler, 
1992; Centers for Disease Control and Prevention (CDC), 2009; Coleman, Coleman, & Murray, 
1990; Handmaker, Miller, & Manicke, 1999; Little et al., 1989; Nuckolls, Cassel, & Kaplan, 
1972).  During the postnatal months, maternal substance use has been associated with greater 
risk of child abuse and neglect, loss of custody, and physical, academic, and socio-emotional 
delays in the child (Conners, Bradley, Mansell, Liu, Roberts, & Burgdorf, et al., 2004; Jester et 
al., 2000; McGlade, Ware, & Crawford, 2009).  Additionally, problems with substance use 
directly impact mothers’ physical and mental well-being, often being associated with poorer 
nutrition, higher rates of depression, poorer relationship satisfaction, and increased risk of 
intimate partner violence (Chapman & Wu, 2013; Fleming et al., 2008; Marshall, 2003; 
Mellingen, Torsheim, & Thuen, 2013; Fleming et al., 2008; Jester et al., 2000).   
Pregnancy and the time following birth represent acute periods of adjustment and place 
additional mental and physical demands on the mother, rendering this a time of heightened stress 
and vulnerability for some.  For mothers with histories of substance use problems, their child’s 
health and well-being has been cited as an instrumental motivator for abstinence during 
pregnancy and reduction in use following birth (Fried et al., 1985).  Nevertheless, added stressors 
during pregnancy and the postpartum period also may place some women at risk for continued 
use or relapse.  It has been estimated that 5-20% of women continue to drink after recognizing 
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they are pregnant, and approximately 2-6% of women continue to binge drink while pregnant (4 
or more drinks in one sitting; CDC, 2002; 2009; Chang, 2000; Flynn et al., 2003; Jagodzinski & 
Fleming, 2007; McLeod et al., 2002; Stratton et al., 1996; Ockene et al., 2002; Pirie et al., 2000).  
It has been estimated that 5.4% of women have used illicit drugs such as opiates and opioids, 
stimulants, cannabis, and non-prescribed prescription medication while pregnant (US 
Department of Health and Human Services (USDHHS), Office of Applied Studies, 2013).  
Although these are relatively small percentages, they represent large numbers of women and the 
known risks render these numbers clinically significant.  Furthermore, researchers caution that 
the above statistics are likely underestimates given the likelihood of underreporting (USDHHS, 
Office of Applied Studies, 2010).   
Given the risks involved with maternal substance use, engaging this population in 
treatment has been an ongoing endeavor for clinicians and researchers alike.  However, women 
generally are less likely than men to enter substance use treatment (Greenfield et al., 2007);   
among pregnant and postpartum women who meet criteria for any psychiatric disorder, only 5-
10% have been found to seek treatment (Andersson et al., 2003, 2006; Kelly, Russo, & Katon, 
2001).  Furthermore, studies have shown that women who use substances while pregnant are 
likely to have fewer monetary resources, less education, histories of abuse and trauma, and less 
access to healthcare (Brady, Visscher, Feder, & Burns, 2003).  These factors also serve as 
barriers to treatment; thus the most vulnerable members of the community are more likely to 
struggle with substance use around the time of pregnancy and experience more challenges 
gaining access to care.  Given the continued prevalence of prenatal substance use and its impact, 
efforts to improve treatment accessibility are imperative.  
Treatment Barriers 
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Women, and specifically mothers, face a number challenges that deter help seeking 
behavior.  These obstacles include a complex intertwining of instrumental, emotional, and ethno-
cultural factors. 
Instrumental barriers.  Instrumental barriers are those that involve monetary resources 
or one’s physical ability to seek treatment.  Particularly for mothers, these barriers include child 
care needs, lack of insurance, time, transportation, and financial constraints (Caplan & 
Whittemore, 2013; Dworkin et al., 2017; Goodman, 2009).  Given these barriers, the 
appropriateness of available treatment models has been called into question.  Most extant 
substance use treatments are based on individualistic, male-based recovery models and do not 
cater to the specific needs of women or mothers (Copeland & Hall, 1992; Finkelstein, 1993).  
Traditionally, many treatment programs require extended stays and do not offer childcare 
assistance (Breibart, Chavkin, & Wise, 1994).  Furthermore, many treatment options are limited 
to private insurance holders and do not provide transportation assistance (Breibart, Chavkin, & 
Wise, 1994).  Lastly, many stand-alone mental health treatment providers will not accept 
pregnant users into treatment due to liability concerns (Lester, Andreozzi, & Appiah, 2006).  
Thus the availability of substance use treatment for pregnant women is both limited and at times 
inaccessible for those with constrained resources.   
Emotional, stigma, and cultural barriers. Emotional barriers are those that involve 
mistrust in treatment providers or fear of negative repercussions as a result of treatment 
engagement.  One of the most prevalent and impactful emotional barriers to substance use 
treatment among pregnant and postpartum mothers is fear of being separated from their children 
as a result of child protective service involvement (Jessup, Humphreys, Brindis, & Lee, 2003).  
Given mandatory reporting laws and the likelihood of child protective service involvement 
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regardless of child placement outcomes, this often is a realistic fear with which mothers seeking 
treatment have to contend.   
Fear of stigmatization is another emotional barrier that has been widely studied and is of 
particular concern for pregnant and postpartum mothers struggling with substance use.  Vogel 
and colleagues (2007) defined stigma as “a mark or flaw resulting from a personal or physical 
characteristic that is viewed as socially unacceptable.”  Studies demonstrate that even during 
recent years the general public has espoused negative attitudes about people with identifiable 
disorders or those seeking mental health care (Angermeyer & Dietrich, 2006; Crisp, Gelder, Rix, 
Meltzer, & Rowlands, 2000; Vogel, Wade, & Haake, 2006).  Furthermore, societal views of 
substance use as a moral failing or a result of weak willpower intensify the stigma attached to 
those experiencing substance use problems, resulting in more punitive and unforgiving attitudes 
toward mothers (Finkelstein, 1994; Jessup & Green, 1987).  Studies have indicated that public 
stigma is perceived and internalized by mothers struggling with substance use, and the resulting 
feelings of inadequacy as a mother, as well as guilt and shame, can discourage women from 
seeking help (Jacobs, 2014).  In many cases potential clients fear judgment not only from 
providers, but also from their families and social circles, leaving many mothers socially isolated 
in their efforts to stop or reduce substance use (Jessup et al., 2003; Mayer & Timms, 1970).   
Some research indicates that the negative impacts of perceived stigma on treatment 
engagement may be compounded for ethnic minority individuals.  Gary (2006) proposed that 
ethnic minority individuals experience “double stigma” as a result of societal marginalization 
based on racial discrimination combined with marginalization due to mental illness.  In partial 
support of this theory, Nadeem and colleagues (2008) found that Black immigrant women were 
more likely than White women to report stigma-related barriers to mental health care.  However, 
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differences between White and other minority participants in this study were not observed.  
Although Nadeem and colleagues’ (2008) study was not specific to women with substance use 
concerns, the findings may be translatable to this specific population.   
It also has been proposed that ethnic minority individuals may experience compounded 
threats of stigma due to specific cultural values.  For instance, individuals from more 
collectivistic cultural backgrounds may perceive greater threats of stigma if they believe that 
exposing a mental health or substance use problem would stigmatize their family as well (Gary, 
2006).  Individuals from more collectivistic backgrounds also may be more influenced by the 
opinions of family members and fear of negative feedback from family members may inhibit 
help-seeking behaviors.  As an example, Caplan and Whittemore (2013) interviewed Latina 
women who met criteria for depression and experienced abuse within their families.  They found 
that women who attributed their depressive symptoms to their experiences of family violence did 
not expect their families to be supportive and expected to be blamed for their experiences.  They 
cited these as reasons for not seeking help from family members or treatment programs.  Caplan 
and Whittemore (2013) also determined that participant responses evidenced strong values of 
familismo (strong identification with, attachment to, and loyalty within one’s family) and 
marianismo (feminine submissiveness and self-sacrificing generosity).  Caplan and Whittemore 
(2013) concluded that collectivistic cultural values, traditional gender roles, and fear of negative 
responses from family members influenced participants’ choices to keep their problems to 
themselves and not seek assistance.   Thus, certain cultural values regarding fealty towards one’s 
family may be in conflict with help-seeking behaviors when perceived threats of stigma are 
present.   Given that perceived stigma is a well-documented treatment barrier among many 
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mothers with substance use concerns, it is possible that felt stigma due to racial discrimination or 
familial repercussions may augment stigmatic effects in this population as well.   
Other emotional or cultural barriers may persist as a result of communal attitudes toward 
mental health care.  For instance, past negative experiences with providers as a result of 
discriminatory practices or language barriers may lower a community’s overall confidence in 
western treatment models and in turn effect lower rates of treatment engagement.  Furthermore, 
in social circles where professional mental health care is used less frequently, awareness of 
available services may be lacking (Diez Roux, 2012).  As those with fewer monetary resources 
are less likely to engage in treatment, awareness of available services may be particularly lacking 
in lower income communities (Diez Roux, 2012).  Thus emotional and instrumental treatment 
barriers are usually overlapping, and at times compounded by ethno-cultural factors for some 
individuals.     
Treatment Studies 
Unfortunately, treatment barriers not only impact lower income and ethnic minority 
individuals’ access to care but also their representation in the treatment literature.  Most studies 
of substance use treatment for pre- and post-natal mothers have recruited women from obstetric 
centers, thereby testing substance use treatment on samples of already treatment-engaged 
individuals and women who likely have more resources at their disposal.  Many of these samples 
have been constituted primarily of white, middle class, English-speaking women.   Despite this 
limitation, studies have provided some meaningful indications for improving treatment access for 
women.   
Residential care.  Research has indicated that meeting the gender-specific and parenting 
needs of women can lead to better substance use treatment outcomes.  For instance, Copeland 
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and Hall (1992) compared characteristics of female patients choosing to attend a female-centered 
versus a coed inpatient substance use treatment facility.  Aside from gender distributions, the 
treatment programs differed in specific programming content and whether children were allowed 
to accompany patients in the female-centered treatment facility.  The researchers found that 
women choosing to enter the female-only treatment program were more likely than women in the 
coed facility to have young children, to identify as lesbian, to have a mother with a history of 
substance use problems, and to have been subjected to sexual abuse during childhood (Copeland 
& Hall, 1992).  This study indicated some significant barriers to substance use treatment, 
including childcare needs and histories of trauma that might lead women to avoid coed treatment 
groups and require specific treatment approaches.  Copeland and Hall (1992) concluded that 
programs attempting to meet gender-specific needs may reach a sector of the population that 
might not otherwise seek treatment, or perhaps drop out of treatment prematurely. 
Integrated health care programs.  Within samples of pregnant and postpartum women, 
researchers found that integrated substance use treatment programs have demonstrated promise 
in meeting the needs of pregnant and postpartum mothers.  These programs take a holistic 
approach to substance use treatment in order to address substance use as well as other areas of 
well-being that might influence women’s sobriety or challenge their ability to engage in 
treatment.  Such programs typically combine case-management, psychological, and medical 
services.   
Jansson and colleagues (1996) evaluated the outcomes from one such program and 
compared them with outcomes from a group of matched controls.  Participants were patients at 
the Center for Addiction and Pregnancy, a comprehensive care program developed by the 
Maryland State Alcohol and Drug Abuse Administration and the Johns Hopkins Bayview 
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Medical Center.  Participants were primarily African-American (85%) and demonstrated some 
high risk characteristics upon admission, including high unemployment rates (67.7%), criminal 
justice system involvement (16.1% on probation or parole and 56.5% endorsing previous 
arrests), and histories of mental health concerns including depression (48.4%), anxiety (21.0%), 
and suicidal ideation (32.3%).  Jansson and colleagues (1996) found that compared to women in 
the comprehensive care program, matched controls were 2.5 times more likely to have infants 
requiring NICU stays.  Furthermore, NICU stays were, on average, six times longer for controls 
than for infants of women participating in the comprehensive care program.  Collectively, the 
savings in hospital costs amounted to about $5,000 per mother-infant pair.  Two later studies 
demonstrated that a particularly important component of integrated care programs might be case 
management services, as intensifying or providing more case management has been related to 
better treatment retention, lower substance use rates, and higher rates of child custody retention 
(Jansson et al., 2003; 2005).  
Meta-analytic and systematic reviews of integrated program outcome data have reported 
similarly positive findings.  One meta-analysis of ten studies from 1990 to 2009 found that 
integrated substance use programs, compared to non-integrated stand-alone substance use 
treatment, were related to better birthing outcomes including higher birth weights, larger head 
circumferences, fewer birth complications, fewer positive toxicology screens, and fewer pre-term 
births (Milligan et al., 2011b).  Milligan and colleagues (2011b) also found that participation in 
integrated programs was related to more prenatal visits.  More recent systematic reviews of 
integrated substance use treatment for mothers have corroborated these findings.  Niccols and 
colleagues (2012a) examined child outcomes in a literature review of 13 studies of integrated 
substance use treatment for mothers from 1990 to 2011.  Two of these studies included non-
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treatment comparison groups; the collective results of these studies indicated that children of 
women in the integrated programs demonstrated superior outcomes in terms of growth 
measurements following birth (i.e., weight, height, and head circumference) as well as emotional 
and behavioral development.  Niccols and colleagues (2012b) conducted a separate systematic 
review of integrated substance use programs and found similarly positive effects for mothers.  Of 
the 31 studies reviewed (dated from 1990 to 2011), three were randomized trials that included 
treatment-as-usual comparison groups.  These studies collectively attributed a small effect in 
improved parenting to the integrated substance use programs.  Furthermore, these studies found 
that improvements in parenting skills were related to particular aspects of the integrated 
programs, including participation in attachment-based parenting interventions and having one’s 
children live with them at the facility.  Improvements in parenting also were found to be related 
to overall maternal mental health and well-being (Niccols et al., 2012b).  In terms of treatment 
engagement, a systematic review by Milligan and colleagues (2011a) found that integrated 
treatment programs, compared to non-integrated treatment programs, were related to more days 
in treatment.  It is likely that the success of integrated healthcare programs lies primarily in their 
ability to address many of the barriers described above due to their multifaceted, wraparound 
approach and variety of care providers.  Furthermore, some researchers have suggested that 
access to prenatal medical services may serve as a gateway to mental health care involvement, 
and that combining services obviates the need for patients to navigate the sometimes limited 
availability of stand-alone mental health services (Bien et al., 1993).  
Family therapy models.  Some research has indicated potential benefits for moving 
away from individualistic models of therapy to offering substance use treatment in the context of 
couple or family therapy.  A brief intervention trial by Chang and colleagues (2005) offered 
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partner-involved treatment to obstetric patients who had engaged in prenatal alcohol use.  A total 
of 304 pregnant women and their partners were randomized to the brief intervention condition or 
assessment only control group. Participants in the brief intervention condition received a single 
25 minute session delivered by a nurse practitioner or the study’s principal investigator. This 
session was formatted to include a knowledge assessment with feedback, a section on contracting 
and goal setting, behavior modification, and a summary discussion.  Following the post-
intervention assessment, Chang and colleagues (2005) found that alcohol use declined for both 
the treatment and control groups, but among pregnant women identified as heavy drinkers at the 
time of study enrollment, the brief intervention was more effective than assessment alone.  
Chang and colleagues (2005) also were able to test the potential benefit of including a partner in 
treatment, as an unintended subsample of 14 participants had partners who did not participate in 
the brief intervention. Thus, Chang and colleagues (2005) compared the results of this subsample 
to the 118 participants who received the brief intervention as planned. Ultimately they found that 
the brief intervention was more effective for heavier drinking women who participated with a 
partner.  Given the prior research that has indicated the benefits of partner-involved treatment 
(McCrady et al., 1991; 2009; 2017), it seems plausible that the presence of a partner could have 
accounted for the observed treatment gains. However, it also is possible that participants with 
absent partners represented a subsample with overall lower levels of social support or perhaps 
greater relationship distress. The lack of randomization for this analysis makes it difficult to rule 
out this possibility or draw causal conclusions regarding the benefit of partner-involved 
treatment.  Nevertheless, these findings suggest a potential benefit of focusing treatment efforts 
on environmental and social factors in addition to individual factors. 
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Brief interventions in primary care settings.  Individual treatment for pre- and post-
natal substance use has often been studied in brief intervention format using participants from 
obstetric care offices.  Fleming and colleagues (2008) spearheaded one such study through their 
Healthy Moms Project. This research initiative recruited women who were receiving routine 
postpartum care. Potential participants were screened initially and determined to be at high risk 
of alcohol misuse based on their quantity and frequency of use prior to or during pregnancy.  In 
total, 235 participants were randomized to receive the brief intervention or usual care. The brief 
intervention consisted of four 15 minute sessions, guided by motivational interviewing and 
cognitive behavioral therapy concepts. At six months following treatment, Fleming and 
colleagues (2008) found that women who received the brief intervention reduced their alcohol 
use to a significantly greater extent than the control group.  
In another study, Yonkers and colleagues (2012) conducted a trial of a brief intervention 
for pregnant mothers that combined motivational enhancement therapy with cognitive behavioral 
therapy into six 30 minute sessions delivered by trained nurses. These sessions were 
administered at an obstetrics office, alongside the patients’ prenatal and immediate postpartum 
care appointments. This intervention was compared to a brief advice condition, which was 
delivered by the participants’ physicians and lasted about one minute per visit. The outcome of 
interest was days of use in the three months prior to and three months following delivery. 
Yonkers and colleagues (2012) found that both the intervention and brief advice control groups 
demonstrated a typical pattern of reducing their combined drug and alcohol use over the course 
of pregnancy and increasing use following delivery. However, Yonkers and colleagues (2012) 
found no significant differences between groups in the percentage of using days during the two 
assessment periods, before and after delivery.  
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In a more recent study, Rubio and colleagues (2014) presented data from a randomized, 
controlled, effectiveness trial of a brief motivational enhancement intervention for pregnant 
mothers. Participants were 330 women who were at least 20 weeks pregnant at the time of 
enrollment, and who had reported at least weekly alcohol use or a binge of four or more drinks 
during the year prior to their pregnancy. Participants in the treatment condition were given five 
sessions of brief motivational enhancement therapy (Miller, Zweben, DiClemente, & Rychtarik, 
1992). Overall, Rubio and colleagues (2014) found that the brief motivational intervention was 
not significantly more effective than the treatment-as-usual control condition.  
Overall, neither study that began during pregnancy demonstrated significant treatment 
effects. One aspect that Yonkers et al. (2012) and Rubio et al. (2014) had in common is that, 
perhaps in part because they were recruiting during pregnancy, many of the women in their 
studies had already reduced or ceased substance use at the time of assessment, thereby limiting 
the amount of change that could occur over the course of treatment. Both Yonkers et al. (2012) 
and Rubio et al. (2014) used past substance use as an indicator of risk. Yonkers and colleagues 
(2012) assessed for substance use prior to pregnancy, and Rubio and colleagues (2014) assessed 
for substance use in the 28 days prior to intake, likely toward the beginning of patients’ 
pregnancies. However, substance use at the start of the prenatal intervention, which is typically 
lower than pre- pregnancy and early pregnancy drinking rates, was what was compared to 
follow-up assessments. Yonkers and colleagues (2012) acknowledged this possibility of a ceiling 
effect, also noting that their brief intervention might have been more effective in a higher risk 
sample.   
Computerized brief interventions with postpartum women.  As exemplified above, 
many of the intervention studies targeting prenatal or postpartum substance use have been 
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conducted with samples of women receiving routine obstetrics care. A key benefit of recruiting 
from obstetric care facilities is that it targets women who might not otherwise seek treatment for 
their substance use. Brief interventions in primary care settings might address some barriers by 
providing a convenient way to receive services while getting routine medical care. Brief 
interventions also have the potential to be cost effective for both the patient and the hosting clinic 
(Handmaker, Miller, & Manicke, 1999; Handmaker & Wilbourne, 2001; Jannson et al., 1996; 
McCollister & French, 2003). Furthermore, brief interventions might serve as stepping stones to 
other treatment providers and community services if longer-term counseling is desired.  
Nevertheless, interventions based in obstetric clinics neglect a substantial portion of the 
target population, particularly those who may lack the resources to seek routine obstetric care; 
and much of the research on prenatal alcohol use in primary care facilities has been conducted 
with samples of primarily white non-Hispanic, middle class, English-speaking women (e.g., 
Chang et al., 2005; Fleming et al., 2008; Wilton et al., 2009).  Ondersma and colleagues (2014) 
noted that although not all women seek routine prenatal care, most women in the U.S. give birth 
in hospitals.  Thus conducting hospital intervention trials with women shortly after birth may be 
a way to target a more representative sample.  Ondersma and colleagues (2005; 2007; 2014; 
2016) developed a computerized substance use intervention, intended to be integrated with 
routine hospital care following birth.  The intervention is delivered in a single session by an 
animated narrator and involves three major components guided by motivational interviewing and 
brief intervention tenets: (a) computerized feedback based on the participant’s self-reported drug 
use, consequences, and readiness to change, (b) elicited interaction in which the participant 
chooses from a list of pros and cons those that are most applicable to themselves, and (c) a 
summary and optional goal-setting.  Randomized trials of this intervention have been conducted 
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for both alcohol and drug use.  In each study, participants were recruited from hospital settings 
shortly after giving birth, and samples were constituted primarily of lower income, African 
American mothers (81.3%-97.2%).  An earlier randomized trial of this intervention (2007) was 
tested with women who reported high-risk illicit drug use prior to pregnancy.  Participants were 
assessed for drug use shortly after birth and reassessed four months following.  A significant 
effect was found favoring the intervention group, such that controls tended to demonstrate higher 
levels of drug use at the four month follow-up assessment.  A later randomized trial of the 
computerized intervention (2014) found that drug use was lower for the intervention group 
compared to controls at three months follow-up, but not six months follow-up.  This indicated 
that although the intervention demonstrated some initial gains, benefits were not maintained over 
the extended assessment period.  This may have been due partially to additional components 
offered in the earlier randomized trial that were not included in the later randomized trial; the 
omitted components included an incentive for seeking additional treatment and two added 
motivational mailings.  Ondersma and colleagues (2016) also tested this computerized 
intervention with recently postpartum women demonstrating high risk alcohol use prior to 
pregnancy.  Although qualitative data indicated that the intervention was well-received by 
participants (Ondersma et al., 2005), quantitative measurement of alcohol use trends following 
birth indicated no significant differences between the intervention group and controls at three 
months follow-up (Ondersma et al., 2016).  It is possible, again, that these samples were 
representative of slightly lower risk individuals given that inclusion criteria were based on pre-
pregnancy rather that during-pregnancy substance use rates.  In line with human-delivered brief 
intervention research, it is possible that computerized brief interventions might be more effective 
with higher risk samples.  It also is possible that human factors such as empathy and positive 
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regard are crucial and partially accountable for the lack of effects demonstrated by computerized 
interventions.   Although computerized brief interventions have yielded mixed results, it is 
possible that their demonstrated accessibility and feasibility warrant further research 
consideration.      
Interventions with community samples.  In continued effort to address the gap in 
diversity within treatment samples, some researchers have sought participants outside medical 
care settings.  As an example, O’Connor and Whaley (2007) conducted brief intervention trials 
in 12 Special Supplemental Nutrition Programs for Women, Infants, and Children (WIC) centers 
in Southern California. They recruited a low income minority-majority sample of 345 pregnant 
women who were still drinking at the time they were screened. Participants were randomized to 
either the brief intervention or an assessment-only condition. As a part of the usual WIC 
program, participants were already receiving individual nutrition education. The brief 
intervention in this study involved adding a workbook to be completed at these meetings with a 
nutritionist. The workbooks included components of education and feedback, cognitive 
behavioral techniques, goal setting, and contracting related to alcohol use. Follow-up data 
indicated that women who had received the brief intervention were five times more likely to be 
abstinent by the third trimester, compared to women who had received assessments only. 
In another minority-majority sample, Field and colleagues (1998) provided educational 
and social services to adolescent postpartum mothers in a vocational program.  The treatment 
group consisted of poly-substance using mothers who had had substance-exposed pregnancies.  
Outcomes from this group were compared to two control groups: one without substance use 
histories and one with substance use histories who did not receive treatment.  Participants in the 
treatment condition attended half-day sessions of school, which included vocational and 
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parenting classes along with social skills, self-care, and substance use treatment.  The substance 
use treatment portion included group therapy, psychoeducation, urine tests, 12 step self-help 
groups, and individual therapy.  Participants were additionally provided with instrumental 
support through child care, vocational advisement, and housing assistance.  Several health 
indicators were monitored over the course of the intervention and compared between groups.  At 
the start of treatment, substance-using participants were significantly higher on measures of 
depression and anxiety, and assessed to have inferior interactions with their infants, compared to 
non-substance using participants.  By the 6th month of treatment, these differences between 
groups had diminished.  They also found that compared to non-treatment controls, the mothers 
with drug exposed pregnancies demonstrated fewer incidents of relapse, fewer repeat 
pregnancies, higher rates of school completion, and more job placements following the program.    
Thus the success in multiple domains reported by this study seems to mirror the multiple benefits 
found by other wraparound service providers as described above (Milligan et al., 2011a; Niccols 
et al., 2012b).   
Collectively, the above treatment studies indicate that pre- and post-natal substance use 
interventions seem to be most successful when targeting high risk clients, providing instrumental 
support, and taking into account the client’s larger social context.   Given the evidence that some 
interventions might be particularly helpful for more disadvantaged women (Field et al., 1998; 
O’Connor & Whaley, 2007), an ongoing challenge is to determine what discourages women 
from seeking treatment so that those barriers can be addressed.  Seeking study samples from the 
community in lieu of medical centers may help illuminate these barriers, and yield more 
generalizable findings through the recruitment of more diverse samples.   
Alternative Treatment and Help-Seeking Preferences 
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There is consistent evidence to suggest that immigrant and minority community members 
continue to be an underserved population in treatment.  For example, in a survey study of 
pregnant and postpartum adolescents entering substance use treatment, Coleman-Cowger (2012) 
found that despite comparable levels of treatment need as indicated by co-occurring diagnoses, 
criminal justice system involvement, and histories of trauma, African American and Hispanic 
girls received less mental health treatment compared to their Caucasian counterparts.  
Furthermore, substance use treatment outcome data indicate poorer outcomes for Latinx clients 
relative to the general population, despite comparable levels of overall use (Alvarez et al., 2007).  
Given these treatment disparities, some investigators have looked into whether ethno-cultural 
background influences help-seeking preferences, and whether alternative support is sought in 
lieu of western health services.  Data on women’s help-seeking preferences are lacking for 
mothers with pre- or postnatal substance use concerns; however several studies have examined 
the treatment preferences of pregnant and recently postpartum women experiencing depression 
or other emotional problems.  For instance, Alvidrez and Azocar (1999) found that Black, Latina, 
and White women in obstetrics settings collectively preferred individual therapy and 
psychoeducational classes about general health, followed by group therapy, prevention 
programs, and mood management classes.  Medication was found to be least desirable.  Nadeem 
and colleagues (2008) interviewed women from low-income service providers, such as WIC and 
Title X family planning clinics, and sought to determine whether ethnic differences were seen in 
treatment experiences and preferences.  Their sample was made up primarily of U.S.-born Black 
participants (n=873) and immigrant Latina participants (n=736), along with U.S.-born White 
participants (n=145), Immigrant Black participants (n=101), and U.S.-born Latina participants 
(n=33).  Participants who had self-identified as having an emotional problem were asked about 
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their preferences and experiences with five different sources of help including medication, 
individual counseling, group counseling, family and friend support, and faith.  The researchers 
found that only 10% of those with an emotional problem were receiving mental health treatment.  
Of the entire sample that endorsed having an emotional issue, whether or not they were receiving 
treatment, differences by ethnic group were seen in which help sources participants viewed as 
potentially helpful.  With the exception of U.S.-born Latinas, minority women were less likely 
than White women to report psychotropic medication as potentially useful.  Differences also 
were seen in therapy preferences, as immigrant Latinas were more likely to endorse individual 
and group therapy as potentially helpful compared to White women.  In terms of alternative 
forms of support, minority women, minus the U.S-born Latinas, were more likely than White 
women to report faith and spirituality as potentially helpful.  Groups did not differ in their 
endorsements of family and friends as potential sources of support.  Most of the participants in 
this sample were uninsured, which likely affected participants’ access to care and could have 
influenced attitudes about treatment.  In a U.K. study, in which participants were recipients of 
universal healthcare, some differences in help-seeking preferences still were noted.  Within a 
sample of White British, Black Caribbean, and Bangladeshi participants who met criteria for a 
mental health problem, Rüdell and colleagues (2008) found that White participants were more 
likely than the other groups to use self-help strategies and seek social support, and less likely to 
engage in faith-based healing practices.  Both White and Black participants reported greater use 
of complementary treatments such as massage or traditional healers.  Bangladeshi participants 
were more likely to endorse medication as a treatment choice, relative to the other groups.  
Immigration status also was related to treatment preferences, as self-help strategies, social 
support, and complementary treatment were endorsed more by non-migrants and participants 
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who had migrated as children, compared to adult migrants.  Faith based treatment was preferred 
less by non-migrant participants, compared to the two migrant groups.  Overall, Rüdell and 
colleagues (2008) also found that, rather than serving as a replacement for western medicine, 
seeking help from family and traditional healers was related to the use of primary care.  This 
finding suggests that those who seek help for a mental health issue may do so in a variety of 
ways, whereas those who are less likely to seek help through Western means also may be less 
likely to seek help from family or community members. Whether greater flexibility in help-
seeking preferences actually influenced mental health outcomes was not assessed in either of the 
above studies, but some researchers have indicated that flexibility, rather than access to any one 
particular type of care, is a key component in health disparity outcomes (Diez Roux, 2012).   
Neither of the above studies was specific to pre- and postnatal mothers with substance 
use concerns; studies of alternative help seeking behaviors and preferences in this population are 
lacking. Given the disparities in women seeking substance use treatment, especially women of 
ethnically diverse backgrounds, clarifying the factors that underlie differences in attitudes about 
treatment in this population is needed.  
Health Disparity Models 
Mechanisms underlying the observed disparities in women seeking substance use 
treatment have not been fully clarified.  However, a number of causal and mediating factors have 
been suggested as influencing the persistence of disparities in health more generally. As an 
example, the Fundamental Cause Model posits that social conditions perpetuated by socio-
economic disparities are the root causes of health disparities via their impacts on access to care 
(Diez Roux, 2012).  Under the original model developed by Link and Phelan (1995), it was 
proposed that health disparities persist over time because of a consistent socioeconomic gradient 
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in society, in which people of higher socio-economic status consistently have access to a wider 
range of resources, which allows for greater flexibility in their ability to take preventative health 
measures and obtain higher quality care when needed. Such instrumental advantages include 
financial solvency, mobility, time flexibility, access to technology, and knowledge of available 
resources (Diez Roux, 2012; Jessup et al., 2003; Phelan, Link, & Tehranifar, 2010; Yonkers et 
al., 2012).  Although there is substantial evidence to support this model, it has a singular focus 
on socio-economic barriers, neglecting the potential roles of cultural and attitudinal barriers.  
Williams (1997) expanded upon the original Fundamental Cause Model to include culture, racial 
prejudice, economic structures, and political and legal inequalities as fundamental causes of 
racial health disparities.  Under this model, racial prejudice is explained to underlie legal policies 
and ensuing economic structures that systematically limit socioeconomic mobility.  Thus through 
racism, race has been associated with socioeconomic status, which in turn, directly impacts 
health.   
A key characteristic of the Fundamental Cause Model is its emphasis on distal causes that 
persist over time (i.e., SES and ethnicity).  In contrast, the Pathways Model of health disparities 
gives greater consideration to the mediating pathways through which SES and ethnicity are 
linked with health outcomes (Diez Roux, 2012).  Some of the proposed mediating pathways have 
included barriers and resources, acculturative processes, and health care.  It is thought that these 
pathways are more mutable than distal underlying causes (Diez Roux, 2012).  Thus, while 
focusing on mediating pathways neglects the larger structure of social injustice to some extent, 
attending to mediating pathways may be one way to effect more immediate change on a smaller 
scale. 
Ethno-Cultural Identity as a Key Factor in Substance Use Treatment Disparities 
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Diez Roux’s (2012) Pathway Model suggests that acculturative processes may serve as 
mediating pathways underlying the relation between SES and health outcomes.  The association 
between instrumental resources and mental health outcomes has been well established among 
pregnant and postpartum mothers struggling with substance use.  However, the role of cultural 
factors in this relationship has been given little attention in the pre- and postnatal substance use 
literature.  Outside the literature on pre- and postnatal substance use, several studies have 
indicated the potential for cultural identity to have strong associations with substance use, and in 
some cases, serve as a protective factor.   
Acculturation and enculturation have been studied extensively in relation to substance 
use, particularly among immigrant community members.  Sun and colleagues (2016) 
operationalized these constructs as “adaptation into mainstream group” (acculturation) and 
“adherence to culture of heritage” (enculturation).  Much of the research on substance use and 
acculturation has been done using male, adolescent, or college samples, and they converge on a 
similar conclusion regarding the positive association between acculturation and higher rates of 
substance use (Gil, Wagner, & Vega, 2000; Ortega et al., 2000; Schwartz et al., 2010).  More 
specific to women and substance use, Vega and colleagues (1998) found that within a sample of 
Mexican-origin California residents, acculturation was associated with greater drug use among 
both men and women; however the effect was stronger for women. In a clinical trial sample of 
Hispanic participants, Lee and colleagues (2014) found that acculturation was not associated 
with alcohol use in men; however acculturation was associated with more hazardous drinking in 
women.  Thus findings from both a community and treatment sample have indicated stronger 
associations between acculturation and substance use among Hispanic women, relative to their 
male counterparts.     
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Unfortunately most studies in the substance use literature focus unitarily on acculturation, 
neglecting the potential protective factor of enculturation.  Furthermore, given that mainstream 
cultural values have the potential to conflict with cultural values of heritage, enculturation and 
acculturation have been frequently conceptualized as mutually opposing processes. Although 
there is literature to support an inverse association (e.g., Berry & Annis, 1974), study outcomes 
for this construct frequently have been influenced by unilinear measurement models. Using 
bilinear measurement models, several studies have demonstrated a more nuanced process by 
which individuals may endorse both acculturation and acculturation strongly (integration), either 
acculturation or enculturation alone (assimilation or separation, respectively), or neither 
(marginalization; e.g., Berry, et al. 1989; Yoon et al., 2013). Nevertheless, some studies still 
indicate a potentially conflicting association, particularly when taking family contextual factors 
into account (Dinh et al., 2013)   
Research generally has indicated that an integrated cultural identity is related to more 
favorable mental health outcomes, whereas scoring high on acculturation alone has been 
associated with more negative outcomes.  Reflecting this, one meta-analysis analyzed 325 
studies and categorized study dependent variables into positive mental health outcomes versus 
negative mental health outcomes, concluding that high endorsement of both acculturation and 
enculturation (integration) was most strongly associated with more positive mental health 
outcomes (Yoon et al., 2013).  Within a sample of Latino men seeking substance use treatment, 
Lopez-Tamayo, Seda, and Jason (2016) found that patients who endorsed higher enculturation 
values reported fewer years of substance use while in treatment.  While acculturation appears to 
have negative associations with substance use outcomes, this association appears to be strongly 
moderated by enculturation.  Thus ethnicity as well as flexibility with one’s ethnic identity 
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appears to influence health behaviors; however how this relationship manifests among mothers 
with substance use concerns is unknown.    
Original Study Aims and Hypotheses 
 Given the disparities in help-seeking and receipt of services among women with 
substance use concerns, particularly pregnant and postpartum mothers of low income and 
minority background, a clearer picture of where and why needs are being unmet is needed for 
this specific population.  Since most studies of treatment needs and perceived barriers have been 
based on treatment seeking samples, more studies of individuals who are less treatment engaged 
and more economically and ethnically diverse are needed.  To remedy these gaps in the 
literature, this study had three overarching aims: (1) to characterize the help seeking preferences, 
perceived treatment barriers, and attitudes about substance use treatment of pregnant and 
postpartum women with histories of substance use problems, in an ethnically diverse, bilingual 
sample from low-income sectors of the community; (2) to examine the relation between 
perceived barriers and (a) help seeking preferences, (b) attitudes about professional treatment, (c) 
treatment engagement, (d) substance use, and (e) subjective well-being; and (3) to determine 
whether the associations tested in aim 2 are moderated by cultural identification.  
Aim 1: Characterize help seeking preferences, perceived treatment barriers, and 
attitudes about substance use treatment.     
Aim 1a. Help seeking preferences.  Among pregnant and postpartum mothers endorsing 
a substance use problem, which treatment types or care resources are perceived as more or less 
desirable?  
Hypothesis 1a-1: Individual therapy will be endorsed more frequently relative to group 
therapy, faith-based support, and medication.   
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 Hypothesis 1a-2: Differences between ethnic groups will be seen such that mothers of 
minority background will report more favorable attitudes toward faith-based services, relative to 
white counterparts. 
Aim 1b. Perceived treatment barriers.  Among pregnant and postpartum mothers 
endorsing a substance use problem, what are their perceived barriers to substance use treatment? 
Hypothesis 1b-1: Participant reports will reflect higher scores on stigma-related relative 
to non-stigma-related barriers to treatment.   
Hypothesis 1b-2: Participants of ethnic minority background will report more stigma-
related barriers, relative to white participants.   
Aim 1c. Attitudes about substance use treatment. How do pregnant and postpartum 
mothers with substance use concerns perceive professional treatment services?   
Hypothesis 1c: Women of ethnic minority background will report less positive attitudes 
about professional substance use treatment than non-minority participants.   
Aim 2: Perceived barriers’ association with substance use, treatment, and mental 
health.  Among pregnant and postpartum mothers with substance use concerns, how are 
perceived treatment barriers related to (a) help-seeking preferences, (b) attitudes toward 
professional care, (c) treatment engagement, (d) substance use, and (e) subjective well-being?   
Hypothesis 2a: Endorsement of more treatment barriers will be related to fewer help 
seeking preferences. 
Hypothesis 2b: Endorsement of more treatment barriers will be related to more negative 
attitudes about professional treatment. 
Hypothesis 2c: Endorsement of more treatment barriers will be associated with lower 
levels of treatment engagement. 
 25 
 
Hypothesis 2d: Endorsement of more treatment barriers will be related to greater severity 
of substance use. 
Hypothesis 2e: Endorsement of more treatment barriers will be associated with lower 
levels of subjective well-being.   
Aim 3: Cultural identity as a moderator.  Does high endorsement of both enculturation 
and acculturation moderate the associations specified in Aim 2?  
Hypothesis 3a: High endorsement of both enculturation and acculturation will serve as a 
moderating protective factor, such that participants identifying as high on both scales will 
demonstrate weaker associations (specified in Aim 2) relative to participants identifying as 
separated, assimilated, or marginalized (see Figure 1).   
Method 
Participants 
Participants were 27 women, ages 23-43 (M = 31 years). Study inclusion criteria required 
that participants be (a) 18 or older, (b) able to speak English or Spanish, (c) currently pregnant or 
recently postpartum (within two years of giving birth), and (d) positively screened for 
problematic substance use (either within the past year, or a year prior to their pregnancy).  
Problematic substance use was determined by a minimum score of 8 on the AUDIT (Saunders et 
al., 1993) or 3 on the DAST (Skinner 1982).  Sources of recruitment for the present study sample 
included substance use treatment centers (n = 21), WIC offices (n = 2), temporary housing 
programs (n = 1), online community boards (n = 1), and word of mouth (n = 2; see Table 1). 
Participants self-identified as Hispanic (44.4%), White (25.9%), Native American 
(14.8%), Multi-Ethnic (11.1%), or African American (3.7%). All participants spoke English, and 
nearly half (n = 13) were bilingual in a second language (primarily Spanish, n = 10).  Average 
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annual household income was $22,036; although 37.0% of the sample reported $0 income and 
81.5% of the sample met poverty guidelines for financial, medical, and/or nutritional assistance 
(NM Human Services Dept., 2018a; 2018b). Most participants were medically insured (96.3%) 
and born in New Mexico (70.4%).  At the time of study interviews, 9 (33.3%) participants were 
pregnant and 18 (66.7%) participants were postpartum. Participants reported a mean of 1.5 
children living in the home. Additional sample demographic information is provided in Table 2.  
Measures  
Qualitative interview.  A short qualitative interview was conducted and included the 
following questions: (a) Tell me about your family; who lives with you at home?  (b) From your 
perspective, do you believe alcohol or drug use has been a problem in your life?  (c) Have you 
ever received treatment for alcohol or drug use in the past? If yes, what helped encourage you to 
seek treatment and attend appointments?  What did you learn or gain from treatment?  (d) What 
about seeking treatment was difficult or undesirable? 
Demographic information.  Demographic information was collected using the 
Demographic Interview 2.2 (CASAA Research Division, 1997).  This measure included 
questions regarding age, gender, ethnic identity, employment status, household income, and 
education.  The Demographic Interview 2.2 was adapted to include bi-ethnic and multi-ethnic 
identity options as well as questions to elicit the participant’s country of birth, number of years 
lived in the United States, and health insurance status.  
Barriers to substance use treatment.  Barriers to treatment were assessed using the 
Barriers to Access to Care Evaluation scale version 2 (BACE v2; Clement et al., 2012).  The 
measure was adapted to be specific to substance use treatment.  In its original form, the BACE is 
a 36-item measure that includes subscales for stigma-related and non-stigma-related barriers.  
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Items query participants about their experience of barriers such as “feeling embarrassed or 
ashamed” (stigma-related) or “having problems with childcare while I receive professional care” 
(non-stigma-related).  Response options range from 0 (“not at all”) to 3 (“a lot”), with higher 
scores indicating a greater barrier to treatment.  It ends with spaces for an open-response option 
to record participant-reported barriers that were not listed in the measure.  The BACE v2 has 
been shown to have acceptable internal consistency (α = .72; Kuhl et al., 1997) and good test-
retest reliability (kappa values .61-.80; Clement et al., 2012).  A shortened 30-item version of the 
measure was developed by omitting five of the original items that garnered low response rates 
and combining two of the original items that yielded high correlations (BACE v3; Clement et al., 
2012).  Although the shorter BACE v3 has been recommend for future use, the BACE v2 was 
administered for the present study as the BACE v3 was not developed using a sample of 
pregnant or postpartum women with substance use concerns, and some of the items omitted 
appeared relevant to this population. Within this study sample, the adapted measure showed 
good internal consistency for the full measure, as well as its stigma and non-stigma subscales (α 
= .93, α = .89, α = .89, respectively). 
Drug Use.  Severity of drug use was measured using the Drug Abuse Screening Test 
(DAST-10; Skinner et al., 1982).  The DAST was developed as a brief screener for harmful drug 
use.  The DAST-10 is a shortened version of the original 20-item measure.  It consists of 10 
questions about drug use behavior, with binary “yes” or “no” response options.  In its original 
20-item form, tests within a clinical sample yielded strong internal consistency reliability (α = 
.92; Skinner 1982).  Within a clinical sample of 501 patients, DAST scores between 5 and 6 were 
85% accurate in detecting drug use disorders according to DSM-III criteria, indicating scores 
within that range could be used as a benchmark for problematic drug use (Gavin et al., 1989).  
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The shorter DAST-10 has been validated cross-culturally.  Within a clinical sample of Spanish 
speakers in Mexico, a cutoff score of 3 identified 98% of the patients with a substance use 
disorder determined by the Mini International Neuropsychiatric Interview 5.0 (MINI 5.0; 
Villalobo-Gallegos et al., 2015).  Within the same sample, reliability was strong (α = .80; 
Villalobo-Gallegos et al., 2015).  However, among a sample of pregnant women screened for 
drug use, hair and urine analysis indicated 24% of participants tested positive for drug use and 
the DAST sensitivity in detecting use was determined to be only .47 (Grekin et al., 2010).  This 
finding indicated that this self-report measure may be less effective when used to assess drug use 
during pregnancy.  Hence for the present study, two time periods were assessed: past year and 
the year prior to pregnancy.   
Alcohol Use.  Severity of alcohol use was assessed using the Alcohol Use Disorders 
Identification Test (AUDIT; Saunders, Aasland, Babor, de la Fuente, & Grant, 1993).  This is a 
measure intended to detect harmful levels of drinking and the possible presence of an alcohol use 
disorder (Allen, Reinert, & Volk, 2001).  Ten items ask respondents to rate their drinking 
behaviors on five- and three-point Likert-type scales, yielding scores that range from 0 to 40 
(e.g., “How often do you have six or more drinks on one occasion?”).  A cutoff score of 8 has 
been suggested as indicating hazardous alcohol use (Conigrave, Hall, & Saunders, 1995).  The 
AUDIT has demonstrated good internal consistency (Cronbach’s alphas in the .80s; Allen, 
Litten, Fertig, & Babor, 1997) as well as good test-retest reliability (r = .88; Daeppen, Yersin, 
Landry, Pecoud, & Decrey, 2000).  For the present study, two time periods were assessed: past 
year, and the year prior to pregnancy.   
Help seeking preferences. An adapted measure from Nadeem and colleagues (2008) was 
intended to assess help seeking preferences, engagement, and flexibility.  In a study of mental 
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health care preferences within an ethnically diverse sample, Nadeem and colleagues (2008) 
asked participants who had indicated an emotional problem, “Do you think these problems could 
be helped with any of the following?”  Participants were asked to provide “yes” or “no” 
responses to five items: “medication, individual counseling, group counseling, family and friends 
support, and faith.”  This measure was adapted to include a category for complementary health 
practices.  The initial question was adapted to be specific to substance use concerns.  
Endorsement of a greater number of categories was expected to indicate greater flexibility in 
participants’ treatment preferences. Internal consistency for the adapted measure was low (α = 
.53).   
Attitudes about professional treatment.  Attitudes regarding professional treatment 
were measured using the abbreviated Attitudes Toward Seeking Professional Psychological Help 
scale (ATSPPH; Fischer & Farina, 1995).  This is a 10-item measure, shortened from its original 
29 item form (Fischer & Turner, 1970).  Respondents are instructed to read statements and 
indicate their “agreement, probable agreement, probable disagreement, or disagreement.”  Items 
include statements such as “The idea of talking about problems with a psychologist strikes me as 
a poor way to get rid of emotional conflicts,” and “If I were experiencing a serious emotional 
crisis at this point in my life, I would be confident that I could find relief in psychotherapy.”  The 
ATSPPH has demonstrated good internal consistency (α = .84) as well as good test-retest 
reliability (r = .80 over one month; Fischer & Farina 1995).  The language in this measure was 
adapted for gender agreement to reflect the female respondents in the present study, as well as to 
be more specific to substance use treatment and “counseling” rather than psychotherapy. Internal 
consistency on the adapted measure was acceptable (α = .66). 
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Treatment engagement.  Items 8-15, 22-25, and 29-35 from the Form 90 (Miller, 1996) 
were used to assess treatment engagement, including types of treatment sought and time spent in 
treatment.  The Form 90 in its original form includes a calendar measure and is intended to 
assess substance use, time in treatment, and some aspects of general functioning over the course 
of 90 days.  The items that were used for this study, including days in religious attendance, days 
in medical care, and days in inpatient treatment, have shown good temporal stability (r = .79-.98, 
.74-.99, .63-.99, respectively; Tonigan, Miller, & Brown, 1997; Westerberg, Tonigan, & Miller, 
1998).    
Subjective well-being. Subjective well-being was measured using the Satisfaction with 
Life Scale (SWLS; Diener et al., 1985).  This is a five-item measure in which participants read a 
series of statements and are asked to rate the extent to which they agree or disagree with each 
statement.  Four response options are presented on a Likert-type scale and range from 1 
(“strongly disagree”) to 4 (“strongly agree”), with higher scores indicating greater life 
satisfaction.  Items include statements such as “The conditions of my life are excellent,” and “In 
most ways my life is close to my ideal.”  The SWLS has demonstrated high internal consistency 
(α = .87) as well as acceptable temporal stability (r = .87 over 2 months and .54 over four years; 
Pavot & Diener, 1993).  However, the measure also has been shown to be sensitive to changes in 
clinical samples undergoing treatment (Pavot & Diener, 1993). 
Acculturation and enculturation.  Acculturation and enculturation were measured using 
the Abbreviated Multidimensional Acculturation Scale (AMAS-ZABB; Zea et al. 2003).  The 
AMAS-ZABB is a 2-subscale instrument developed to measure acculturation and enculturation 
in three dimensions: identity, cultural competence, and language competence.  Respondents are 
asked to rate 42 items on a 4-point Likert-type scale ranging from 1 (“strongly disagree” or “not 
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at all”) to 4 (“strongly agree” or “extremely well”).  Higher scores are indicative of higher levels 
of acculturation or enculturation.  As an example, one of the acculturation items asks, “How well 
do you know popular American newspapers and magazines?” One of the enculturation items 
asks, “How well do you speak your native language with family?”  Within a sample of Latino/a 
participants, the AMAS-ZABB demonstrated good internal reliability for both the acculturation 
and enculturation scales (α = .89 and .96; Zea et al., 2003).   
Procedures 
The original recruitment plan included face-to-face recruitment of women at four local 
WIC centers; yet ultimately the WIC Director for NM determined that this procedure was 
inconsistent with WIC policy. The centers did, however, continue to support recruitment flyers 
being left available in their waiting rooms. Study investigator and research assistants additionally 
distributed bilingual recruitment flyers at community centers (e.g., parks, libraries, laundromats, 
thrift and grocery stores), medical offices and hospitals, behavioral health treatment centers, 
online community boards, and through email and newsprint advertisement. In-person recruitment 
took place at a farmers market, flea market, and health fair. See Figure 2 for participant 
recruitment and retention data, and Table 1 for a full list of recruitment sources.   
Recruitment flyers included the study description, eligibility criteria, and contact 
information. Interested participants called the number on the flyer to get more information and to 
be screened for eligibility.  Study personnel were bilingual Spanish and English speakers.  All 
phone conversations were conducted in the caller’s preferred language, determined by either how 
the caller initiated the conversation, the language used in their voice message, or by asking the 
caller about their language preference.  Interested and eligible participants were then scheduled 
for an interview appointment. Although this issue did not arise, screenings and interviews were 
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set to be rescheduled if signs of intoxication were present.  For the interview appointment, 
alcohol intoxication was tested using saliva test strips.   
 Participants attended a 60-minute appointment at the Center on Alcoholism, Substance 
Abuse, and Addictions (CASAA). Appointment procedures were available in English and 
Spanish.  The participants’ language preferences were typically determined through their initial 
phone screens, though study materials and interviews were available in English and Spanish at 
all times.  During the interview appointment, participants were first guided though consent 
procedures.  These included giving the participant a copy of the consent agreement to read, 
followed by the interviewer explaining key points of the agreement (i.e., their right to end 
participation at any time without penalty, confidentiality limitations, potential risks and benefits), 
and lastly offering to answer any remaining questions about the study before signing the consent 
document.  A copy of the informed consent agreement was given to the participant to keep.   
 After consent was provided, the assessment portion of the study began with a short 
qualitative interview, during which responses from the participant were written down by the 
interviewer.  Participants were then guided through a series of written questionnaire measures.  
Participants were given the option of completing the measures on their own or having the 
questions read to them out loud by the study investigator.  At the end of their appointment, 
participants were given a list of potentially helpful community resources, asked if they had any 
questions or concerns about the study, and given a $25 gift card for their participation.   
Data Analysis 
 Prior to testing study hypotheses, basic descriptive statistics were generated to 
characterize the sample on socio-demographic, independent, and dependent variables.  Next, 
preliminary analyses were conducted to ensure that the underlying statistical assumptions for the 
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planned analyses were upheld.  This included checking for normal measurement distributions, 
absence of multicollinearity, homoscedasticity, and linear relationships between independent and 
dependent variables.  Once underlying statistical assumptions were assessed, the hypotheses for 
aims 1-3 were tested. In the case of assumption violation, alternative steps were taken to address 
the study aims and hypotheses. These alternative approaches are introduced briefly below and 
discussed more thoroughly in the results. Lastly, qualitative data from participant interviews 
were used to further characterize the study sample and allow for added quantifiable data.  
Aim 1: Characterize help seeking preferences, perceived treatment barriers, and 
attitudes about professional care.     
Aim 1a. Help seeking preferences.  ANOVA was the planned analysis to assess 
differences between help-seeking preference categories (e.g., individual or group therapy, faith-
based support, and medication), as well as differences based on ethnic identity (hypotheses 1a-1 
and -2).  Due to severely limited variability within the Help-Seeking Preferences scores, items 
from the Form 90 Treatment Engagement measure were used to assess participants’ use of 
individual counseling, medication, and religious service attendance.  Although these items assess 
participants’ use of services rather than  their preferences, the items address support services 
comparable to those assessed in the Help-Seeking Preferences measure (i.e., counseling, 
medication, and religion/spirituality).  The items therefore were used to best approximate 
participants’ treatment decisions, despite acknowledging that other factors besides preference 
may factor into their treatment decisions.  Unfortunately these items did not assess for use of 
group therapy, specifically.  To ensure that the appropriate statistical assumptions were met, a 
Wilcoxon test was used to assess differences between types of support. A Mann-Whitney U test 
was used to examine potential differences between cultural groups. 
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Aim 1b. Perceived barriers.  A paired t-test was used to test for differences between 
stigma and non-stigma barrier types (hypothesis 1b-1).  Given that these subscales are unequal in 
size, comparisons between scales were made using average scores in lieu of raw totals. Given 
that underlying assumptions appeared to have been met by these measures, the planned 
hierarchical regression analyses were performed to test for ethnic differences in stigma and non-
stigma barriers (hypothesis 1b-2). Given the small, uneven subsamples of white (n = 6) and non-
white (n = 20) participants, the 1b-2 analyses were performed using additional indicators of 
cultural identity. These included measures of enculturation and second language fluency.   
Aim 1c. Attitudes about substance use treatment. Hierarchical regression analyses were 
performed to test for ethnic differences in attitudes about professional treatment, while 
controlling for socio-demographic variables such as income and education (hypothesis 1c). As 
with hypothesis 1b-2 above, this analysis was carried out with three separate indicators of 
culture: ethnicity, language, and enculturation.  
Aim 2: Perceived barriers’ associations with substance use, treatment, and mental 
health.  Bivariate correlations were used to examine the association of perceived treatment 
barriers with (a) help-seeking preferences, (b) attitudes toward professional care, (c) treatment 
engagement, (d) substance use, and (e) subjective well-being (hypotheses 2a-e).  The BACE 
stigma and non-stigma subscales also were entered into the matrix to characterize their unique 
associations with help-seeking preferences, attitudes about professional care, treatment 
engagement, substance use, and subjective well-being.  
As the Help-Seeking Preferences measure was severely limited in its variability, Form 90 
Treatment Engagement items measuring medication use, therapy use, and days in religious 
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attendance, were used in its place to facilitate interpretations of a potential relation between 
treatment barriers and use of specific support services.  
Aim 3: Cultural identity as a moderator.  Scores on the enculturation and acculturation 
subscales of the AMAS-ZABB were initially intended to characterize participants as highly 
acculturated/less enculturated, highly enculturated/less acculturated, high on both scales, or low 
on both scales.  Given the small size of the present sample and the lower variability shown in the 
acculturation scale, a revised plan sought to test enculturation as a continuous measure of 
cultural identity and its impact on associations identified in Aim 2. Hierarchical regressions or 
partial correlations (depending on assumption verification) were expected to test for cultural 
influence on the association between perceived treatment barriers and (a) help-seeking 
preferences, (b) attitudes toward professional care, (c) treatment engagement, (d) substance use, 
and (e) subjective well-being (hypothesis 3a).  
Thematic content analysis of qualitative response data. In line with recommendations 
by Maguire and Delahunt (2017), steps were taken to (a) generate codes based on subsets of the 
data, (b) discuss unifying themes between coders, (c) code remaining subsets of the data, and (d) 
modify or add themes to fit the data following each coding session. This was an open coding 
method, as codes were developed in an iterative process. There is literature to suggest that 
qualitative studies typically achieve thematic saturation with nine to 12 participants (e.g., Guest, 
Brunce, & Johnson, 2006; Hennink, Kaiser, & Marconi, 2017), thus this analysis method was 
expected to suit the present study sample size. 
Results 
Sample Characteristics  
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Within the present sample, most participants (55.6%, n = 15) reported subthreshold levels 
of alcohol use and were admitted to the study solely on the basis of reported substance use 
behaviors. A substantial portion of the sample (37.0%, n = 10) was admitted to the study on the 
basis of both illicit substance use and alcohol use. Only two participants (7.4%) reported 
problematic alcohol use without co-occurring illicit substance use. Collectively, mean AUDIT 
scores for the sample were 6.81 for the year preceding their study interview and 9.52 for the year 
preceding pregnancy. Mean DAST scores were 4.93 and 7.74 for the years prior to study 
participation and their pregnancy, respectively. Among participants reporting illicit substance 
use, opiates and methamphetamine were most frequently named as primary drugs of choice (see 
Table 4). In terms of treatment engagement, a small portion of the sample (n = 3, 11.1%) 
reported no experience with treatment for drug or alcohol concerns; they did, however, report 
past experience with treatment for other emotional or psychological concerns. Most participants 
reported at least some experience with substance use treatment over the course of their lifetime, 
ranging between 1 and 730 days in counseling, residential, and/or detox programs. In the 90 days 
preceding their last use, participants reported an average of 7.37 days (SD = 17.66) engaged in 
substance use treatment. During this same time frame, participants reported an average of 37.00 
days (SD = 42.45) taking prescribed maintenance medication, and 27.89 days (SD = 40.00) 
taking medication for other psychological concerns. Additional descriptive statistics for the 
independent and dependent measures are available in Table 3.  
Testing Statistical Assumptions  
Distribution statistics for all independent and dependent measures can be viewed in Table 
3. Distribution assumptions were upheld for the following measures: Barriers to Access to Care 
Evaluation and its subscales, Attitudes Toward Seeking Professional Help, Satisfaction with 
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Life, and 90-Day use of medication for mood and psychological concerns. Distributions for 90-
Day use of opioid maintenance therapy and the DAST (for the year prior to study participation) 
were approaching normality. The remaining measures of substance use (AUDIT, DAST for the 
year preceding pregnancy), treatment engagement (Form 90 items assessing lifetime engagement 
and 90-day use of non-medication services), Help-Seeking Preferences, and 
acculturation/enculturation (AMAS-ZABB) failed to meet standard distribution assumptions. 
Multicollinearity was checked using the bivariate correlation statistics listed in Table 5, which 
gave no indication of redundancy between variables. Homoscedasticity and linear associations 
between variables also were ensured prior to carrying out the inferential tests below.  
Aim 1: Characterize Help Seeking Preferences, Treatment Barriers, and Attitudes about 
Treatment.     
Aim 1a. Help seeking preferences.  Among pregnant and postpartum mothers endorsing 
a substance use problem, which treatment types or care resources are perceived as more or less 
desirable? Within this sample, the vast majority of participants endorsed all sources of mental 
health support, specifically individual therapy (96.3%, n = 26), group therapy (92.6%, n = 25), 
medication (81.5%, n = 22), family and friends (96.3%, n = 26), religion and spirituality (85.2%, 
n = 23), and alternative or complementary practices (85.2%, n = 23). 
Hypothesis 1a-1: Individual therapy will be endorsed more frequently relative to group 
therapy, faith-based support, and medication.  Overall, the Help Seeking Preferences measure 
did not allow for enough variance to detect differences in preferences for the different support 
sources. Items from the Form 90 Treatment Engagement measure indicated a more variable 
response pattern when asking participants about their actual use of support services in the 90 
days prior to their last use. During this time frame, 18 (66.7%) participants took medication to 
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help with a psychological or substance use issue, 12 (44.4%) participants sought counseling for 
their substance use, and 11 (40.7%) attended a religious or spiritual gathering.  A Wilcoxon 
Signed Ranks Test indicated no significant difference in participants’ use of substance use 
counseling (M = 3.33 days, SD = 5.64) versus religious or spiritual support (M = 2.11 days, SD = 
3.85); Z = -.74, p = .46). The test indicated significantly more frequent use of psychotropic (M = 
27.89 days, SD = 40.00) and opioid maintenance medications (M = 37 days, SD = 42.45) relative 
to days spent in counseling (Z = -2.20, p = .028; Z = -3.24, p < .001, respectively); although 
given that these medications are often prescribed for daily use, this difference does not 
necessarily indicate a difference in participants’ perception of helpfulness or favorability of 
medication over counseling services. Thus, although these results do not conclusively support or 
reject the hypothesis that individual therapy would be favored over other types of support, these 
results appear to characterize the present sample as generally open to various types of mental 
health support.  
 Hypothesis 1a-2: Differences between ethnic groups will be seen such that mothers of 
minority background will report more favorable attitudes toward faith-based services, relative 
to white counterparts. The Mann-Whitney Tests did not detect significant differences between 
minority and non-minority participants, nor between bilingual and mono-lingual participants, in 
their use of different types of support (see Table 6).  These results are inconsistent with the 1a-2 
hypothesis that mothers of minority background would report more favorable attitudes regarding 
faith-based services, relative to white participants. Nevertheless, it should be noted that these 
analyses were based on participants’ actual use of sources of support versus their expressed 
attitudes about the source of support. 
 39 
 
Aim 1b. Perceived barriers. Among pregnant and postpartum mothers endorsing a 
substance use problem, what are their perceived barriers to substance use treatment?  Overall, 
this sample indicated a broad range of experience with treatment barriers, with total raw scores 
ranging from 11 to 94 (M = 57.93, SD = 25.04). 
Hypothesis 1b-1: Participant reports will reflect higher scores on stigma-related 
relative to non-stigma-related barriers to treatment. To account for the unequal number of items 
in the stigma and non-stigma subscales, mean subscale scores were computed for each 
participant (potentially ranging 0 to 3), and comparisons between the subscales were made using 
these scores in lieu of raw total scores. Results from a t-test analysis supported the above 
hypothesis, such that participants reported significantly greater impact from stigma-related 
barriers (M = 1.70, SD = .81) than non-stigma barriers (M = 1.28, SD = .58) in terms of their 
access to treatment; t (26) = 3.95, p < .001. Furthermore, limiting the non-stigma scale to 
instrumental barriers alone also continued significant differences, such that participants reported 
greater impact from stigma barriers (M = 1.70, SD = .81) than instrumental barriers (M = 1.35, 
SD = .69); t (26) = 2.74, p = .011).   
Hypothesis 1b-2: Participants of ethnic minority background will report more stigma-
related barriers, relative to white participants. On average, both White and non-White  
participants rated stigma-related barriers as interfering “quite a lot” with their treatment 
engagement on a 0 to 3 scale (M = 1.89, SD = .84; M = 1.64, SD = .81, respectively). Inspection 
of both average and raw stigma scores suggested a potential difference between White (raw M = 
24.57, SD = 10.88) and non-White participants (raw M = 21.30, SD = 10.57) in a direction 
opposite of the one hypothesized, such that White participants appeared to report greater 
experience of stigma barriers. However, this observed difference was not significant when tested 
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with a hierarchical regression, ∆R2 = .019, ∆F (1, 25) = .490, p = .491. Additional analyses were 
conducted to explore potential differences based on enculturation and second language fluency, 
but significant effects were not detected (∆R2 = .017, ∆F (1, 25) = .441, p = .513; ∆R2 = .002, ∆F 
(1, 25) = .057, p = .813, respectively). 
Aim 1c. Attitudes about substance use treatment. How do pregnant and postpartum 
mothers with substance use concerns perceive professional treatment services?  The sample 
mean score of 30.88 (SD = 4.91) on the Attitudes Toward Seeking Professional Psychological 
Help scale indicated that, on average, participants rated themselves as being in probable 
agreement with positive statements about professional treatment. However, scores ranged from 
20 to 39, indicating a spread of both negative and positive views on professional care.   
Hypothesis 1c: Women of ethnic minority background will report less positive attitudes 
about professional substance use treatment than non-minority participants.  Mean total scores 
were similar between White (M = 31.00, SD = 6.25) and non-White participants (M = 30.60, SD 
= 4.54). Hierarchical regression analyses were used to assess for potential cultural differences in 
attitudes about professional care, while controlling for socio-demographic variables such as 
income and education.  As with aim 1b above, this analysis was carried out with three separate 
indicators of culture. However, significant effects were not detected on the basis of ethnicity 
(∆R2 = .009, ∆F (1, 23) = .226, p = .639), enculturation (∆R2 = .061, ∆F (1, 23) = 1.544, p = 
.227), or second language fluency (∆R2 = .007, ∆F (1, 23) = .168, p = .685).  
Aim 2: Barriers’ Associations with Substance Use, Treatment, and Life Satisfaction. 
Based on the analyses performed, treatment barriers were not significantly associated 
with participants’ substance use behavior, attitudes toward professional care, treatment 
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preferences, time spent in treatment, or general life satisfaction. The results from these bivariate 
correlations are listed in Table 5. 
Hypothesis 2a. It was hypothesized that endorsement of more treatment barriers would 
be related to fewer help seeking preferences. Given the limited variability and psychometric 
properties of the Help-Seeking Preferences measure, subscales from the Form-90 Treatment 
Engagement measure were entered into the analysis to account for actual support services used. 
These included days spent in religious attendance, attending therapy, and taking medication. 
Nevertheless, a significant association was not demonstrated (see Table 5).  
Hypothesis 2b. It was hypothesized that endorsement of more treatment barriers would 
be related to more negative attitudes about professional treatment. This was not supported by the 
analysis results (see Table 5).  
Hypothesis 2c. It was hypothesized that endorsement of more treatment barriers would 
be associated with lower levels of treatment engagement. Days spent engaged in various 
treatment types, during the participant’s lifetime and 90 days since last use, were entered as 
separate variables in the analysis. However, treatment engagement during neither time frame 
demonstrated a significant association with barriers (see Table 5).   
Hypothesis 2d. It was hypothesized that endorsement of more treatment barriers would 
be related to greater severity of substance use. This was not supported by the analyses. Given the 
distribution limitations of the DAST and AUDIT measures, days since last use (from the date of 
interview) was entered as an additional substance-use indicator in the analysis. Nevertheless, this 
too was not shown to be significantly associated (see Table 5).  
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Hypothesis 2e. It was hypothesized that endorsement of more treatment barriers would 
be associated with lower levels of subjective well-being. Based on participant’s reports of overall 
life satisfaction, this was not supported by the analysis (see Table 5).   
Aim 3: Cultural Identity as a Moderator.   
Does high endorsement of both enculturation and acculturation moderate the associations 
specified in Aim 2?  It was hypothesized that high endorsement of both enculturation and 
acculturation would serve as a moderating protective factor, such that participants identifying as 
high on both scales would demonstrate weaker associations specified in Aim 2.  The planned 
analyses to detect moderating effects were not conducted given that significant associations were 
not detected for the hypothesized variables. Nevertheless, an overarching aim of the original 
planned analyses was to characterize cultural influences on independent and dependent variables. 
Thus steps were taken to examine direct associations between enculturation and acculturation 
and the independent and dependent variables in this study, as well as to further characterize the 
sample based on these constructs.  
As a sample, all participants scored within the top half of the range on the acculturation 
scale. More variability was demonstrated in the enculturation scale such that six participants 
(22.2%) scored in the lower half of the scale. Given that acculturation and enculturation are 
frequently demonstrated to have an inverse association, it was interesting to find that 
acculturation and enculturation were strongly and positively correlated within the present sample 
(r = .73, p < .001)).  This was thought to have occurred in part due to the inclusion of scores 
from White, non-minority participants. A t-test confirmed that participants’ scores on the 
enculturation scale were significantly related to their ethnic identity, such that participants 
identifying as White endorsed a higher mean Enculturation score (M = 78.57, SD = 4.50), than 
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participants identifying as non-White (M = 63.20, SD = 17.68); t (25) = -2.25, p = .034.  
Consistent with descriptive data suggesting overall high scores on the acculturation measure, 
significant differences in acculturation were not detected between minority (M = 74.58, SD = 
7.59) and non-minority participants (M = 79.36, SD = 5.28); t (25) = -1.53, p = .138. 
Bivariate correlational analyses detected moderate associations for both acculturation and 
enculturation with past year substance use behavior, such that participants who expressed 
stronger acculturation and enculturation identities were likely to report less substance use 
behavior in the past year (r = -.48, p = .011; r = -.48, p = .011, respectively). Results also 
indicated a significant negative relation between the acculturation and enculturation scales and a 
subset of items from the BACE indicating family-related barriers to treatment (r = -.40, p = .042; 
r = -.42, p = .029, respectively). Thus participants who scored lower on scales of Acculturation 
and Enculturation tended to report greater influence from family-related barriers on their 
engagement with treatment.  
Given that acculturation and enculturation are hypothesized to represent pulls between 
one’s culture of heritage and the majority culture, it is possible that including measurement data 
from White non-minority participants may have artificially inflated average scores, increased 
cohesion between the scales, and truncated variance. For this reason, bivariate correlations were 
run separately within each subsample to explore potential associations between acculturation and 
enculturation with the measures of substance use, treatment engagement, and barriers to 
treatment. The results of these analyses are reported in Table 7. Of note, associations of 
enculturation and acculturation with family-related treatment barriers were strengthened within 
the subsample of non-White participants (r = -.66, p < .001, r = -.56, p = .010, respectively).  
Within the subsample of White participants, reports of fewer treatment barriers, especially 
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instrumental and family-related barriers, were strongly associated with participants’ lifetime 
substance use treatment engagement (r = -.84, p = .019, r = -.85, p = .016, respectively). 
Thematic Content Analysis of Qualitative Interview Responses 
Based on participants’ responses to open-ended questions, thematic content analysis was 
used to further characterize the sample and supplement gaps in the quantitative data. Broad 
themes included participants’ household make-up, positive and negative experiences as mothers, 
factors that encouraged treatment engagement, perceived treatment effects, and barriers they 
have experienced. All codes and their frequencies are listed in Table 8. 
Household. A small majority of participants (51.8%, n = 14) were single mothers, 
defined here as living without in-home support from a spouse or romantic partner. Of this subset, 
five women (18.5% of the total sample) lived with other adults, usually parents, step-parents, or 
grand-parents; and nine (33.3% of the total sample) lived alone with their children. Thirteen 
(48.1%) of the participants lived with a spouse or romantic partner, and a small subset of this 
group (n = 2, 7.4% of the total sample) had parents or in-laws living in the home as well.  Of the 
entire sample, most mothers (n = 15, 55.5%) lived with one child, although the number of 
children in the home ranged from 0 (due to custody removal, n = 4) to 7.   
Experiences as mothers. When asked about their favorite parts of motherhood, 
participants most frequently (n = 14, 51.9%) alluded to the affection between them and their 
children or the unique bond that they shared. An additional salient theme emerged as participants 
often described a sense of purpose they felt after becoming mothers (n = 6, 22.2%). For instance, 
one mother stated, “It gives my life more meaning.”  
When asked about the more difficult aspects of motherhood, participants most frequently 
indicated a lack of support as the most challenging aspect (n = 8, 29.6%). One mother explained, 
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“I feel like I’m doing it all alone most of the time.” Several participants also cited an emotional 
toll and the amount of patience that is required (n = 6, 22.2%).   
Treatment engagement. The majority of participants (n = 24, 88.9%) reported past 
experience with alcohol or substance use treatment. Of the subset, most (n = 13, 54.2%) cited 
their pregnancy or their child’s health as the primary impetus to their seeking treatment.  
Participants’ responses regarding what encouraged their treatment engagement varied widely, 
such that more themes with lower frequencies were identified for this broad theme. Nevertheless, 
participants also cited self-determination (n = 3, 12.5%), something to occupy time (n = 3, 
12.5%), and a lack of choice (e.g., court-mandated; n = 3, 12.5%), as factors motivating their 
treatment engagement.  
Perceived treatment effects. When asked about what they gained from treatment, most 
participants (n = 9, 37.5%) alluded to coping skills for managing urges and emotions. A second 
cluster of responses (n = 5, 20.8%) reflected growth in self-compassion. One participant shared, 
“I’m learning it’s okay. I’m a work in progress.” A range of experiences were represented in this 
sample, as some (n = 4, 16.7%) expressed a lack of treatment gains (e.g., “It’s all talk.”).  
Treatment barriers. When asked about the difficult or undesirable aspects of treatment, 
most participant responses fit within over-arching themes of instrumental (n = 9, 33.3%) and 
emotional (n = 10, 37.0%) barriers. Of the individual sub-themes identified participants most 
frequently mentioned their discomfort with sharing their personal, sometimes traumatic, histories 
with multiple providers (n = 6, 22.2%). As one participant shared, “Opening up about my past, 
repeating myself over and over again to different counselors and psychologists, reopening the 
wound, that was the worst.” Another participant similarly stated, “Explaining my situation to the 
doctors and counselors over and over. This discourages me from wanting to go there.” 
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Additional barrier categories included limited program availability (n = 4, 14.8%), and 
anticipation of withdrawal symptoms (n = 4, 14.8%). 
Lastly, given the limitations of some of the planned quantitative analyses, efforts were 
made to identify information related to the original study variables. In particular, there was 
variability in participants’ appraisal of their treatment experiences, such that four participants 
expressed negative attitudes. Thus, these four cases were examined for potential response 
patterns, particularly in their reports of treatment barriers. No patterns were detected. The rest of 
the participants’ raw response data were examined for themes related to the independent and 
dependent variables specified in Aims 1-3. Although treatment barriers and attitudes were 
elicited by the questions, there did not appear to be enough variance in attitude valence to 
identify a pattern of association; the remaining data did not appear comparable to the variables 
specified in Aims 1-3. 
Discussion 
The present study was initiated with three overarching aims in mind. Aim 1 sought to 
examine support preferences, treatment barriers, and attitudes toward treatment within a diverse 
sample of pregnant and postpartum mothers who have endorsed substance use concerns. Aim 2  
sought to examine associations of reported treatment barriers with help seeking preferences, 
attitudes about treatment, treatment engagement, substance use, and life satisfaction.  Aim 3 was 
intended to assess cultural influences on the associations tested in aim 2. Additional efforts were 
made to analyze qualitative interview responses in order to provide additional data to address 
study and to detect unique information that may have been undetected by quantitative measures 
and analyses.      
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Although concerted efforts were made to recruit participants who had not had substance 
use treatment experience, most participants responded to advertisements posted in substance use 
treatment centers, potentially contributing to distributional concerns observed in some of the 
measures (e.g., treatment engagement, help-seeking preferences). Nevertheless, although most 
participants were treatment-experienced, the extent of their experience varied widely. 
Furthermore, they reported substantial impact from a wide range of treatment barriers. A strength 
of the study sample was that it was diverse in terms of ethnocultural and sociodemographic 
representation. 
Although this study was prepared to accommodate mono-lingual Spanish-speaking 
participants, recruitment efforts did not yield participants from this population. Given that mono-
lingual Spanish-speaking pregnant and postpartum women likely represent a small subset of the 
overall population of pregnant and postpartum women, expecting that a smaller subset of this 
population would endorse a substance use concern and elect to discuss it may have been 
overambitious in hindsight. Nevertheless, approximately half of the recruited sample spoke a 
second language (mostly Spanish). Furthermore, given the sample’s minority-majority 
socioeconomic and ethnocultural characteristics, the majority of participants in this sample 
represent perspectives that are underrepresented in the literature, particularly for this special 
population.  
The sample expressed generally positive attitudes toward all forms of mental health 
support listed in The Help Seeking Preferences measure. This measure was intended to gauge 
both treatment preferences and flexibility in support utilization. It is possible that the binary 
response options placed undue limitations on the variance in participants responses. 
Nevertheless, given that most participants had experience with substance use treatment, it is 
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possible that the sample truly held such open and generally optimistic views of the utility of 
different support sources. Qualitative data from participant interviews supported this possibility 
in that most participants were able to generate positive statements about something they gained 
from treatment. If results from this assessment are generalizable, it provides evidence in support 
of other findings indicating that, rather than representing opposing approaches, the treatment and 
support sources listed in this measure may frequently be endorsed together, such that people may 
demonstrate somewhat bimodal distributions in their willingness to seek out support (Rüdell et 
al., 2008) 
The Attitudes Toward Professional Care measure yielded a more balanced distribution. 
Participants indicated, on average, generally positive attitudes toward professional treatment. 
Nevertheless, participants expressed a range of attitudes toward treatment, which included both 
more negative and more positive views on either side of that mean score. Additional analyses 
assessed for differences in attitudes on the basis of cultural variables, including ethnic identity, 
second language fluency, and enculturation; yet cultural effects were not detected. It is possible 
that the small sample size limited the power of these analyses. However, the literature has 
reported highly variable response patters in terms of treatment attitudes and treatment 
preferences on the basis of ethnicity, immigration status, and country location (e.g., Alvidrez & 
Azocar, 1999; Nadeem et al., 2008). Thus while the field would benefit from more definitive 
evidence on this topic, the results reported here are not necessarily in conflict with the extant 
literature. Furthermore, it is possible that between-group differences in treatment attitudes and 
preferences may be highly influenced by availability of and access to treatment. Of note, 96.2% 
of this sample was insured, which is a larger percentage compared to reports from past U.S. 
studies with comparable sample demographics and research aims (Nadeem et al., 2008). It is 
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likely that changes in political climate and public policy  impacts on treatment access will 
continue to have noticeable impacts on the dynamics of treatment access, treatment utilization, 
and attitudes toward professional treatment.  
Despite the fact that most participants had experience with substance use treatment, the 
sample still reported being highly impacted by stigma-related barriers in terms of treatment 
engagement.  In fact, participants  rated stigma barriers as significantly more impactful compared 
to instrumental barriers and all non-stigma barriers, collectively. Given that 81.5% of 
participants met state and federal poverty guidelines and reported a number of instrumental 
challenges in their qualitative interviews, the outcome that felt-stigma was rated as more 
influential than instrumental barriers has strong implications for improving treatment 
engagement in the community. For instance, ensuring that a clinic waiting room and 
administrative staff are perceived as non-judgmental and inviting may be equally important to 
ensuring other aspects of accessibility, such as transportation and insurance coverage.  The 
substantial impact of stigma demonstrated here supports other researchers’ assertions that 
societal stigma directed toward mothers with substance use concerns is largely felt and 
internalized by this specific population (Jacobs, 2014). Moreover, as expressed through 
participants reports of these barriers, societal stigma directed toward this particular population is 
counter-productive to their efforts toward treatment engagement and change.   
Subsequent correlational analyses were intended to assess the strength of associations of 
perceived treatment barriers with measures of help-seeking preferences, attitudes about 
treatment, treatment engagement, substance use and life satisfaction. The analyses did not detect 
significant effects for the hypothesized associations between these variables.  It is possible that 
the small sample size limited the power of these analyses to detect potential effects. 
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Nevertheless, when acculturation and enculturation were entered into the analysis, significant 
negative associations with past year drug use and family-related barriers to treatment emerged. 
Although the substance use association was not further supported by the other substance use 
measures assessed, the result supports the substantial literature indicating a protective impact of 
enculturation on substance use behavior, particularly when acculturation is strongly endorsed as 
well (e.g., Lopez-Tamayo et al., 2016; Yoon et al., 2013).   
A final set of correlational analyses was conducted separately for White and non-White 
participants to more thoroughly assess potential associations with the enculturation and 
acculturation measures cultural, as well as detect potential unique effects based on ethnic 
identity. Within the subsample of non-White participants, associations between enculturation and 
acculturation with family-related treatment barriers were substantially strengthened, whereas the 
same effects had diminished within the subsample of White participants.  This seemed to 
indicate that enculturation and acculturation scores from non-White participants were driving the 
association when analyses were conducted for the sample as a whole.  Within the subsample of 
White participants, reports of fewer treatment barriers, especially instrumental and family-related 
barriers, were strongly associated with participants’ lifetime substance use treatment 
engagement.  Although interpretations were made with caution for this subsample given its small 
size, examination of a scatter plot seemed to indicate a strong linear relationship and the 
associations were consistently significant across all barrier subscales. It was interesting, and 
somewhat perplexing, that this association emerged for White participants alone. Nevertheless, 
aside from ethnic differences, this finding fits with a substantial body of literature indicating that 
women, and particularly mothers, are highly prone to be influenced by family when making 
treatment decisions (e.g., Jessup et al., 2003; Mayer & Timms, 1970). 
 51 
 
 Qualitative analyses allowed for additional supportive data as well as unique information 
that was not detected through quantitative measures. It was a surprise to observe so few stigma-
related treatment barriers in response to a question that elicited many other treatment barriers. 
This was somewhat inconsistent with participants’ reports on the BACE, which indicated a larger 
effect from stigma relative to other treatment barriers. Given the observed inconsistency, it is 
possible that instrumental variables were readily salient and easily generated in number, whereas 
perhaps stigmatic barriers are more likely to demonstrate a strong effect when rated in terms of 
their felt impact.   
 In general, responses to a question asking, “What about seeking treatment was difficult or 
undesirable?” were consistent with many of the treatment barrier items assessed in the BACE. 
However, two unique additional perspectives emerged through the interviews. In particular, 
“fear” of withdrawal symptoms was indicated by several participants as an obstacle to their 
treatment involvement. Second, a substantial number of participants described a common 
experience of needing to retell their personal, sometimes trauma-related, histories to multiple 
providers. Based on examination of the raw data, these experiences seemed to occur due to high 
rates of clinician turnover, interdisciplinary patient care, or the structure of services offered by 
the clinic.  Given the frequency of such a specific and consistent response theme, it is reasonable 
to expect that this experience may not be limited to the women in this study.  
Limitations  
 Limitations in analysis options, power, and interpretations stemmed from the  small 
sample size. Additionally, the study would have benefited from a sample that was balanced with 
participants uninvolved with treatment, as well as mono-lingual Spanish speaking participants as 
originally intended. It is possible that similar barriers to those reported in this study are 
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comparably impactful on this population’s ability or willingness to engage with research, 
including anticipated perceptions of stigma and instrumental barriers including transportation, 
childcare, and the monetary costs of these resources. In hindsight, some of these limitations may 
have the potential to be addressed more effectively in future, similar studies given the lessons 
learned through this one.   
Strengths 
Despite limitations, this study succeeded in recruiting a sample that was diverse in terms 
of socio-economic factors and ethnic identity, thereby addressing a prominent gap in the 
literature. Furthermore, despite the small sample, moderate to large effects were detected that 
have meaningful implications for the treatment and emotional support needs of this population.  
For instance, despite the small sample, a significant and stable effect of perceived stigma on 
treatment engagement was detected. Lastly, qualitative analyses were unhindered by the small 
sample and revealed additional treatment barriers that are likely unique to this special population.  
Future Directions and Conclusions 
 The literature and healthcare community would benefit from further investigation into 
ethnocultural impacts on stigma treatment barriers. Given records of disparities and 
discrimination in healthcare (e.g., Thornicroft, 2008), it seems plausible that stigma may impact 
different and overlapping populations at comparably high levels, but in qualitatively different 
ways. Thus continued examination of both joint and discrete experiences of stigma is needed in 
order to intervene. 
Given that this was a challenging sample to recruit for in-person interviews, future 
studies may benefit from cross-location collaboration using joint or comparable measures. 
Alternatively, qualitative study designs and analytic approaches may be ideal solutions for 
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studying the target population. Ideally research and treatment communities will continue to 
collaborate on efforts to identify and reduce barriers to mental health and substance use 
treatment. 
Although this study sample was limited in size, it gave voice to a collective experience of 
stigma and its subjective impact on treatment engagement. Given that many to most participants 
in this sample were single mothers below poverty cutoffs, the overall rating of stigma as more 
impactful than instrumental barriers was noteworthy.  Sadly, these findings support an 
understanding that women with substance use issues are prone to experience heightened stigma 
during a time of greater need and vulnerability. Nevertheless, the fact that participants most 
frequently cited their children as primary motivations for seeking treatment indicates that this 
may simultaneously be a time of prime opportunity for intervention.  
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Figure 1. Hypothesized Model 
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Figure 2. Participant Recruitment Process 
  
Recruitment flyers distributed to 134+ sites 
(in-person recruitment at 3)
41 people called
33 people screened 8 left messages and could not be reached
30 screened eligible and were scheduled for 
interviews 3 screened ineligible
27 completed interviews 3 no-showed and could not be rescheduled 
 69 
 
Table 1. Recruitment Outreach and Participant Response by Source 
Recruitment Source Participant Return (n) 
1. WIC #1 Broadway  
2. WIC #2 Candelaria 1 
3. WIC #3 South Valley  
4. WIC #4 Alamosa 1 
5. ASAP 21 
6. El Mesquite  
7. Carneceria  
8. Casa de Salud | Isleta & Arenal  
9. 1st Choice Centro Familiar | Avenida & Bridge  
10. Pro’s Ranch Market | Atrisco & Central  
11. Clinica la Esperanza | Atrisco & Central 1 
12. Downtown bus stops  
13. Offices at 625 Silver Street  
14. Heights park light poles  
15. Downtown park light poles  
16. South Valley park light poles  
17. UNM Posting Board | SUB  
18. UNM Posting Board | Duck Pond/ G-lot & Q-lot shuttle stop  
19. UNM Posting Board | Woodward  
20. UNM Posting Board | The Center of the Universe  
21. UNM Posting Board | Regener Hall  
22. Corner near Walmart San Mateo and Carlisle  
23. SW bus stop San Mateo and Carlisle  
24. Given to man at bus stop for his contacts  
25. SE bust stop San Mateo and Carlisle  
26. Bow and Arrow Lodge motel (Central)  
27. Econo Lodge (Central)  
28. Holiday Inn (Central)  
29. Motel 6 (Central)  
30. Rodeway Inn (Central)  
31. Pinon motel (Central)  
32. Unnamed motel San Mateo and Central   
33. EZ Wash Laundromat (Central)  
34. Red Door coffee shop/bar downtown  
35. Train Station downtown  
36. Under bridge near downtown train station  
37. Ppl Plasma downtown  
38. Emailed to Dr. Erika Johnson-Jimenez for doula contacts  
39. Country Club Market | Coal Avenue & 10th street.  
40. Barela’s Community Center | Rio Grande Zoo  
41. Bus Stop | 8th St. & Stover   
42. Wash Tub Laundromat |11th St. and Central  
43. Mary Fox Park | Roma and 13th St.  
44. Light Pole | Gold St. & 1st St.   
45. Bus Stop | Gold St. and 6th St.  
46. El Centro de Igualdad y Derechos | 4th St. & Hazeldine Ave.  
47. NMILC building |Silver St. & 7th St.  
48. Light Pole | Near First United Methodist Church  
49. Hazeldine Park | Hazeldine Ave. & 3rd St.  
50. Bus Stop | Broadway & Central Blvd.  
51. Spin Cycle Laundromat |Atrisco and Central  
52. West Mesa Market | Blue Water & 57th St.   
53. YB Laundromat | Old Coors Dr. & Carlos Rey Circle   
54. All Washed Up Laundromat | Old Coors Dr. & Sage Road  
55. Laundromat | Paisano Center on Coors Blvd.  
56. Wash Tub Laundromat | Rio Bravo & Isleta Blvd.  
57. Division of Vocational Rehabilitation | Isleta Blvd. and Rio Bravo  
58. Adobe Acres Laundromat | Isleta Blvd. & Camino Del Valle  
59. Wash Brite Laundromat | Kathryn Ave. & San Pedro Dr.  
60. The French Quarter Apartments | Paloma Dr. & Ross Ave.  
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61. Jack and Jill Park |San Pedro & Bell Ave.   
62. Jeanne Bellamah Park | Tomasita St & Constitution Ave.   
63. La Michoacana | Zuni & Arizona St.  
64. Wilson Park | Anderson Ave. & Cardenas Dr.  
65. CASAA waiting area  
66. Coop Central and Carlisle  
67. Brenda Frink, Brian Kimber, and Jackie West at Turquoise Lodge  
68. Craigslist Albuquerque 1 
69. Alibi online and print  
70. Thai Vegan restauraunt  
71. Milagro clinic SE Central   
72. Milagro up north  
73. Lovelace Grace Program  
74. Milagro Tucker Ave  
75. emailed to Ali, UNM medical student  
76. El Centro Salvila   
77. S. Valley Farmer’s Market Isleta  
78. Expo NM Flea Market  
79. Barrett House | Constitution & Eubank  
80. Los Altos Park | Lomas & Eubank  
81. Goodwill | Menaul & Juan Tabo  
82. Spin Cycle Laundromat | Juan Tabo & Prospect Ave.  
83. Sunrise Laundromat | Indian School and Tramway  
84. Dollar Tree | Lomas & Morris Ave.  
85. Rudy’s BBQ | Carlisle & I-40  
86. Women’s Resource Center | UNM   
87. UNM Posting Board | Old Education Building  
88. Winning Coffee Café | Harvard & Central  
89. Robinson Park | Central and 8th St.  
90. Rudy’s BBQ | Coors & Alameda  
91. Sudz Laundromat | 4th & Ranchitos Rd  
92. Catholic Charities | Bridge & Pear Rd.  
93. Spin Cycle Laundromat | 4th St & Guadalupe Trail  
94. EZ Wash Laundromat | Griegos Rd & 4th St  
95. Enlace Communitario | Yale & Alamo  
96. Royal Car Wash | Central & Shirley St.  
97. Bus Stop | Central & Wyoming  
98. Tony Hillerman Public Library  
99. Mesa Verde Community Center  
100. Grace Thrift Store | Central & Utah  
101. Mike’s Car Wash | Zuni and Rhode Island  
102. Carniceria Chihuahua | Zuni and Charleston  
103. Phil Chacon Park | Southern & Grove St.  
104. Trumbull Park | Pennsylvania & Trumbull Ave.  
105. Bus Stop | Front of Warren Sandia Apartments  
106. Aspen Ridge Apartments | Louisiana & Continental Loop    
107. Cesar E. Chavez Community Center | Kathryn Ave & Louisiana   
108. Spin Cycle Laundromat | Louisiana & Central   
109. Light pole | Lomas and Carlisle   
110. Copy Center | Harvard and Silver Ave.  
111. Bookcase Used Books | Cornell and Central   
112. Highland Park | Elm & Silver Ave.  
113. Light Pole | 4th and Central near alley   
114. Light Pole | Central and High St.  
115. UNM Posting Board | Outside Zimmerman Library  
116. Women’s Specialists New Mexico | 1001 Coal Ave. Se.  
117. Planned Parenthood | Eubank & Candeleria   
118. Planned Parenthood | Lomas & Louisiana   
119. Care Net Pregnancy Center | Eubank and Candeleria   
120. Domestic Violence Resource Center | Silver & 7th   
121. Goodwill | Juan Tabo & Constitution  
122. 5 Points Indoor Market | Sunset and Bridge  
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123. Light Pole | Near Pinon Motel & Apartments   
124. Katie Avery (former contact), Maternal Health Program, DOH   
125. emailed to Maureen Burns, Families First, DOH, 505-476-8911  
126. emailed to Jessi Sanchez, Maternal Health Program, DOH  
127. Zia Apartments  
128. Other Mothers Thrift Store Montgomery  
129. S Broadway Public Library  
130. Planned Parenthood San Mateo & Marquette  
131. Mental Health Fair  
132. Medical Student Estefania Montanez  
133. El Super S. Valley  
134. Zia Family Focus Center  
135. Word of mouth (Participant heard about study from friend, family, or other) 2 
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Table 2. Demographic Characteristics    
 n (%) M (SD) 
Female 27 (100.0)  
Age   31.15 (4.89) 
Ethnicity   
  Am. Indian/Al. Native 4 (14.8)  
  Black/African Am. 1 (03.7)  
  White 7 (25.9)  
  Hispanic 12 (44.4)  
  Multi-ethnic 3 (11.1)  
Employment   
  Full time 1 (03.7)  
  Part time. 2 (07.4)  
  Homemaker 3 (11.1)  
  Unemployed 21 (77.8)  
Language   
  English 14 (51.9)  
  English and Spanish 10 (37.0)  
  English and other 3 (11.1)  
Education Years  13.67 (3.80) 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 73 
 
Table 3. Independent and Dependent Variables 
 Mean SD Skewness Kurtosis 
Substance Use     
    DAST1 Past Year 4.93 4.23 -.138 -1.832 
    DAST1 Prior to Pregnancy 7.74 3.32 -1.588 1.306 
    AUDIT2 Past Year 6.81 10.42 1.687 2.022 
    AUDIT2 Prior to Pregnancy 9.52 12.22 1.236 .187 
    Days Since Last Use 191.52 248.17 1.298 .843 
Barriers to Treatment     
    Barriers Total 57.93 25.04 -.493 -1.047 
    Barriers Stigma (raw) 22.15 10.54 -.380 -1.256 
    Barriers Non-Stigma (raw) 35.78 16.34 -.279 -1.191 
    Barriers Instrumental (raw) 8.11 4.11 -.683 -.573 
    Barriers Stigma (average) 1.70 .81 -.380 -1.256 
    Barriers Non-Stigma (average) 1.28 .58 -.279 -1.191 
    Barriers Instrumental (average) 1.35 .69 -.683 -.573 
Cultural Identity     
   Acculturation 75.81 7.29 -1.246 1.749 
    Enculturation 67.19 16.74 -1.368 .994 
Life Satisfaction 11.81 4.26 -.297 -.734 
Attitudes toward Treatment 30.70 4.91 -.050 -.580 
Help-Seeking Preferences 5.37 1.01 -2.066 4.522 
Treatment Engagement (over 90 Days) 
    Outpatient Counseling for AUD/SUD 3.33 5.64 2.357 6.259 
    Outpatient Counseling for Other Concerns 1.00 3.15 3.269 10.106 
    Total In/Outpatient Treatment AUD/SUD   7.37 17.66 4.265 19.935 
    Total In/Outpatient Treatment Other   1.00 3.15 3.269 10.106 
    Opioid Maintenance Medication  37.00        42.45 .382 -1.885 
    Other Psychotropic Medication 27.89 40.00 .880 -1.181 
    Religious Attendance  2.11 3.85     2.041 3.074 
Treatment Engagement (Lifetime) 
    Outpatient Counseling for AUD/SUD 115.48        187.37 2.729 7.199 
    Outpatient Counseling for Other Concerns 66.96 162.03 3.374 11.483 
    Total In/Outpatient Treatment AUD/SUD   132.59 196.31 2.311 4.981 
    Total In/Outpatient Treatment Other   67.11 162.48 3.380 11.537 
    Opioid Maintenance Medication  572.04 705.65 1.499 1.524 
    Other Psychotropic Medication 1558.22 2171.45 1.824 3.513 
Note: N = 27, Skewness SE = .448, Kurtosis SE = .872. 1Drug Abuse Screening Test. 2Alcohol Use Disorder Screening Test.  
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Table 4. Primary Drugs of Choice among Participants Endorsing Illicit Substance Use       
 n (%)  
Endorsement of Past Year Use 17 (100.0)  
    Opiates, Opioids 11 (64.7)  
    Methamphetamine, Speed 4 (23.5)  
    Cocaine, Crack 2 (11.8)  
    Cannabis 0 (00.0)  
    Sedatives, Tranquilizers, Barbiturates 1 (17.6)  
Endorsement of Year Prior to Pregnancy Use  24 (100.0)  
    Opiates, Opioids 21 (87.5)  
    Methamphetamine, Speed 9 (37.5)  
    Cocaine, Crack 0 (00.0)  
    Cannabis 4 (16.7)  
    Sedatives, Tranquilizers, Barbiturates 2 (08.3)  
Note: Participants provided the above information following each DAST administration assessing two time frames. Drug 
categories are not mutually exclusive as participants were able to report more than one substance. 
  
 
75 
 
Table 5. Correlations between Independent and Dependent Variables 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 
1 Barriers Total -                   
2 B. Stigma *.89 -                  
3 B. Non-Stig. *.96 *.72 -                 
4 B. Inst. *.82 *.61 *.85 -                
5 B. Family *.78  *.82 *.65 *.59 -               
6 SUD Tx Total -.32 -.34 -.27 -.21 -.27 -              
7 SUD Therapy .18 .05 .23 .23 -.08 .22 -             
8 Other Therapy .15 .22 .09 .16 .17 -.02 .17 -            
9 SUD Meds .02 -.15 .13 .16 -.10 *.41 *.48 .05 -           
10 Other Meds .33 .31 .31 .33 .11 -.12 .05 -.05 .15 -          
11 Religion .23 .27 .18 .04 .14 -.07 .11 .31 .08 -.08 -         
12 Attitudes -.12 -.05 -.16 -.25 -.26 .13 -.03 .09 .12 -.01 .33 -        
13 Life Satisf. .28 .19 .31 .35 .20 .15 -.02 .14 -.03 -.26 .26 .06 -       
14 DAST -.21 -.23 -.18 -.19 -.11 -.08 .36 .00 .16 -.05 -.13 .05 *-.40 -      
15 DAST -.06 -.20 .04 -.21 -.14 .16 .07 -.14 *.44 -.15 -.04 *.43 .08 .24 -     
16 AUDIT .15 .13 .14 .13 .13 -.02 *.39 -.08 .02 .19 -.08 -.17 -.29 .33 -.20 -    
17 AUDIT .06 .14 .00 .06 .12 -.12 .19 .15 .13 .32 .05 .02 -.32 *.38 -.07 *.78 -   
18 Last Use .05 .07 .03 -.00 .03 .14 -.22 -.25 -.11 -.16 -.07 .09 *.47 *-.61 .23 *-.42 *-.44 -  
19 Acculturation -.24 -.19 -.24 -.19 *-.40 -.00 -.20 -.09 -.07 .07 -.04 -.02 .11 *-.48 -.23 -.19 -.22 .36 - 
20 Enculturation -.18 -.13 -.20 -.18 *-.42 .05 -.18 .17 -.13 .04 .20 .18 .23 *-.48 -.14 -.27 -.20 .30 *.73 
Note: *p < .05, *p < .01. 1) Treatment barriers total. 2) Stigma barriers. 3) Non-stigma barriers. 4) Instrumental barriers. 5) Family-related barriers. 6) All substance use treatment including counseling. 
7) Substance use counseling. 8) Counseling for other psychological issues. 9) Opioid maintenance medication. 10) Other psychotropic medication. 11) Religious attendance. 12) Attitudes toward 
Professional Help score. 13) Satisfaction with Life score. 14) Drug Abuse Screening Test, past year use. 15) Drug Abuse Screening Test, year prior to pregnancy use. 16) Alcohol Use Disorders 
Screening Test, past year use. 17) Alcohol Use Disorders Screening Test, year prior to pregnancy use. 18) Days since last use at date of interview. All treatment engagement variables were within the 
90-day time frame.  
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Table 6. Cultural Differences in Support Utilization: Mann-Whitney Test Results       
 Mann-Whitney U Z Sig. 
Between White and Non-White Participants    
    Opioid Maintenance Medication  55.5 -.884 .431 
    Other Psychotropic Medication 66.0 -.258 .850 
    Religious Attendance 44.5 -1.588 .162 
    Substance Use Counseling  60.5 -.578 .607 
Between Monolingual and Bilingual Participants     
    Opioid Maintenance Medication  90.5 -.027 .981 
    Other Psychotropic Medication 75.0 -.906 .458 
    Religious Attendance 75.5 -.847 .458 
    Substance Use Counseling  84.5 -.347 .756 
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Table 7. Correlations between Acculturation, Enculturation, Treatment Barriers, Treatment Engagement, and Substance Use 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1 Enculturation - **.73 -.27 -.25 -.15 **-.66 .13 -.18 -.13 .07 -.41 -.19 -.17 -.15 
2 Acculturation .64 - -.27 -.23 -.08 *-.56 .08 -.11 .04 .21 -.40 -.32 -.09 -.09 
3 Barriers Total .20 -.25 - **.88 **.81 **.74 -.37 .18 .21 .24 -.13 .02 .15 .01 
4 Barriers Stigma .09 -.32 **.97 - **.58 **.79 -.39 .05 .10 .14 -.11 -.11 .15 .09 
5 Barriers Instrumental -.06  -.54 **.91 **.88 - *.56 -.29 .20 .15 .18 -.25 -.20 .07 -.05 
6 Barriers Family-related .08 -.17 **.88 **.90 *.84 - -.30 .16 .25 .18 .07 .06 .18 .12 
7 SUD Tx Total (90 days) -.02 -.54 .24 .12 .31 -.09 - .16 -.11 -.08 -.19 .13 -.07 -.17 
8 SUD Therapy (90 days) -.10 -.63 .20 .10 .30 -.13 **.99 - .08 .13 .33 -.07 .41 .10 
9 SUD Tx Total (Lifetime) .02 .42 *-.79 *-.76 *-.84 *-.85 -.20 -.17 - **.93 -.02 .20 .24 .18 
10 SUD Therapy (Lifetime) .31 .41 *-.78 -.75 *-.83 *-.83 -.22 -.18 **.99 - -.13 .14 .22 .19 
11 DAST past year -.58 -.54 -.54 -.53 -.28 -.49 .44 .51 .14 .12 - .25 .30 .37 
12 DAST prior to pregnancy .62 .18 -.27 -.40 -.30 -.53 .49 .47 .61 .60 .15 - -.21 -.04 
13 AUDIT past year -.68 -.65 .43 .51 .50 .30 .26 .30 -.58 -.58 .06 -.61 - **.79 
14 AUDIT prior to pregnancy -.64 **-.95 .35 .43 .55 .20 .55 .62 -.46 -.45 .40 -.27 *.82 - 
Note: *p < .05, **p < .01. Statistics for White participants are located below the diagonal; statistics for non-White participants are located above the diagonal. 7,9) All substance use treatment including 
counseling. 8,10) Substance use counseling. 11,12) Drug Abuse Screening Test. 13,14) Alcohol Use Disorders Screening Test.  
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Table 8. Coded Interview Responses   
 Frequency (%) 
Favorable Aspects of Motherhood   
Love special bond  14 51.9 
Purpose  6 22.2 
Child's development/watching them grow  3 11.1 
Mom's development  3 11.1 
Watching them be happy 2 7.4 
All/general statement 1 3.7 
Difficult Aspects of Motherhood   
Lack of support  8 30.8 
The attention/patience required  7 25.9 
Financial cost  3 11.1 
Self-doubt re mom skills  3 11.1 
Sleep  3 11.1 
Co-parenting  2 7.4 
Communicating with child  2 7.7 
Worrying about child safety  2 7.4 
Learning how to be a mom  1 3.7 
Watching them change  1 3.7 
Factors Encouraging Treatment Engagement  
 
Pregnancy/child's health  13 48.1 
Self-determination  3 11.1 
Something to occupy time  3 11.1 
Mandated  3 11.1 
Personal health  2 7.4 
Family pressure/support  2 7.4 
"Tired of it"  2 7.4 
Religion spirituality  1 3.7 
Housing security  1 3.7 
 Frequency (%) 
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Group therapy  1 3.7 
Everything else didn't work  1 3.7 
Rapport w providers  1 3.7 
Regain custody  1 3.7 
Self-improvement  1 3.7 
N/A no treatment experience  3 11.1 
Perceived Treatment Benefits   
Emotional fortitude/coping skills  9 33.3 
Self-compassion  5 18.5 
Nothing/don't know  4 14.8 
Empowerment/self-efficacy  3 11.1 
Normalization of challenges reduced sense of isolation  2 7.4 
Help available  2 7.4 
Social skills/healthy relationships  2 7.4 
Regained functionality  1 3.7 
Personal growth  1 3.7 
Effects on child  1 3.7 
Difficult Aspects of Treatment  
 
Emotional Barriers   
 
    Retelling of personal experiences to providers  6 22.2 
    Experiencing difficult emotion or stigma  3 11.1 
    Being told uncomfortable troths 1 3.7 
Instrumental Barriers   
    Financial costs  3 11.1 
    Transportation/distance from clinic 2 7.4 
    Time cost  2 7.4 
    Insurance  2 7.4 
Substance Use-Related   
    Withdrawal symptoms   4 14.8 
    Living without substance use  3 11.1 
 Frequency (%) 
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Program-Related   
    Limited treatment availability  4 14.8 
    Perceived ineffectiveness of program  2 7.4 
Family  2 7.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
